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Abstract	  	   In	   recent	   years,	   the	   use	   of	   manufactured	   nanomaterials	   has	   been	   rapidly	  increasing	   in	   a	   wide	   range	   of	   application	   areas.	   Among	   others,	   these	   areas	   of	  application	  include	  cosmetics,	  medicine,	  clothing,	  and	  sporting	  goods.	  The	  small	  size	  of	  nanomaterials	  offers	  unique	  properties	  that	  are	  not	  possible	  to	  obtain	  by	  the	   same	   material	   in	   bulk.	   Although	   the	   use	   of	   nanomaterials	   holds	   great	  promises	   for	   society,	   the	   increased	   use	   and	   production	   also	   increases	   the	  concern	   that	   engineered	   nanomaterials	   may	   have	   adverse	   effects	   on	   human	  health	  or	  the	  environment.	  Unlike	   chemical	   substances,	   which	   have	   a	   defined	   structure	   and	   mass,	  nanomaterials	  need	   to	  be	  described	  by	  a	   large	  number	  of	  descriptors,	  e.g.,	   size	  distribution,	  shape,	  and	  composition.	   In	  addition,	   to	  address	  possible	  effects	  on	  humans	   or	   the	   environment,	   it	   is	   of	   great	   importance	   to	   determine	   how	  nanomaterials	   interact	   with	   biological	   matter.	   Interactions	   with	   proteins,	   cell	  membranes,	  and	  cells	  may	  cause	  protein	  coronas,	  cellular	  uptake,	  or	  biocatalytic	  processes.	  To	  fully	  characterize	  such	  interactions	  there	  is	  a	  strong	  need	  for	  novel	  analytical	  techniques	  or	  methodologies.	  In	   this	   thesis,	   I	   have	   investigated	   how	   the	   lipid	  membrane,	   one	   of	   the	  most	  vital	   structures	   of	   a	   cell,	   interacts	   with	   various	   types	   of	   nanomaterials	   (e.g.	  polyelectrolyte	   complexes,	   graphene	   oxide,	   and	   TiO2	   nanoparticles).	   The	  interactions	   between	   the	  model	  membranes	   and	   the	   nanomaterials	   have	   been	  studied	   using	   several	   complementary	   surface	   sensitive	   techniques.	   The	   results	  have	   showed	   conformational	   changes	   of	   polyelectrolyte	   complexes	   upon	  adsorption	   to	   the	   membranes	   and	   triggered	   disintegration	   of	   such	   complexes	  upon	   exposure	   to	   an	   acidic	   or	   a	   reducing	   environment.	   Furthermore,	   TiO2	  nanoparticles	  have	  been	  shown	  to	  be	  able	  to	  disrupt	  lipid	  membranes	  in	  a	  Ca2+-­‐mediated	   mechanism	   and	   a	   novel	   nanocomposite	   material,	   composed	   of	  alternating	  layers	  of	  graphene	  oxide	  and	  lipid	  membranes,	  has	  been	  prepared.	  In	  addition,	  the	  quartz-­‐crystal	  microbalance	  with	  dissipation	  monitoring	  technique	  (QCM-­‐D)	  has	  been	  explored	  in	  studies	  of	  intracellular	  transport	  processes	  using	  living	   cells.	   Specifically,	   pigment	   translocation	   in	  Xenopus	   laevis	  melanophores,	  has	  been	  shown	  to	  generate	  significant	  QCM-­‐D	  responses.	  By	  using	  the	  described	  methodology,	   it	   is	   possible	   to	   evaluate	   the	   nanoparticle	   design	   and	   study	   how	  nanomaterials	  behave	  at	  a	  biological	  interface	  or	  effect	  specific	  cellular	  functions.	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1 
Introduction We	   have	   always	   been	   surrounded	   by	   natural	   nanometer-­‐sized	   particles	  (nanoparticles,	  NPs),	  e.g.	  dust	  and	  ash,	  without	  taking	  any	  notice	  of	   it.1	  Foreign	  matter	  in	  the	  body	  is	  in	  most	  cases	  efficiently	  removed	  by	  the	  reticuloendothelial	  system.	   However,	   during	   the	   last	   century,	   particle	   pollution	   due	   to	   human	  activities	   (anthropogenic)	   has	   increased	   dramatically,	   mainly	   because	   of	   the	  industrial	  development	  and	  combustion-­‐based	  engine	  transportation,	  and	  it	  has	  been	   shown	   that	   particle	   pollution	   may	   cause	   severe	   health	   disorders.	   More	  recently,	   during	   the	   last	   decades,	   the	   boom	   of	   nanotechnology	   has	   become	  another	   significant	   contributor	   to	   the	   large-­‐scale	   production	   of	   various	  nanomaterials.	  	  The	  physico-­‐chemical	  properties	  of	  engineered	  nanomaterials	  are	  unique	  and	  make	   the	   materials	   useful	   for	   many	   technological	   and	   medical	   applications.	  Today,	  nanomaterials	  are	  used	  in	  many	  commercial	  products	  including	  clothing,	  sunscreens,	   cosmetics,	   and	   adhesives	   (see	   Chapter	   2	   for	   a	   definition	   and	   an	  overview	   of	   nanoparticle	   occurrence	   and	   application).	   In	   the	   field	   of	  nanomedicine,	   the	   merging	   of	   nanotechnology	   and	   medicine,	   nanomaterial-­‐based	   formulations	   are	   employed	   for	   administration	   of	   drugs	   (common	  nanodrug	   designs	   are	   described	   in	   Chapter	   3).2	   Nano-­‐sized	   drug	   carriers	   are	  predicted	   to	   greatly	   improve	   drug	   administration	   during	   the	   21st	   century.3	   By	  reformulating	   existing	   drugs	   into	   a	   nano-­‐sized	   carrier	   to	   improve	   their	  pharmacokinetics,	  i.e.	  the	  fate	  of	  the	  drug	  after	  administration,	  is	  a	  cost	  efficient	  alternative	  to	  the	  development	  of	  novel	  drugs.	  One	  way	  to	  achieve	  this	  is	  to	  use	  a	  carrier	   that	   allow	   drugs	   to	   more	   efficiently	   be	   delivered	   across	   biological	  barriers,	   and	   even	   targeted	   to	   the	   diseased	   tissue.4	   This	   rapidly	   developing	  methodology	   holds	   a	   great	   promise	   because	   of	   its	   potential	   to	   control	   (i)	   the	  biodegradation,	  (ii)	  the	  bioavailability	  and	  (iii)	  the	  potential	  side	  effects	  of	  a	  drug	  in	  a	  positive	  way.	  	  The	   increased	   use	   and	   production	   volumes	   of	   engineered	   nanomaterials,	  increases	   the	   likelihood	   of	   people	   coming	   in	   contact	  with	   such	  materials.	   As	   a	  consequence	  there	  is	  a	  significant	  concern	  that	  nanomaterials	  may	  have	  adverse	  effects	   on	   the	  human	  health	   and/or	   the	   environment.5	   Such	   lessons	  have	  been	  learned	   in	   the	   cases	   of	   asbestos6,	   and	   air	   pollution	   in	   general7,	  8.	   Asbestos	   is	   a	  term	  for	  a	  group	  of	  fibrous	  minerals	  that	  are	  known	  to	  cause	  lung	  cancer,	  and	  the	  more	  rare	  cancer	  called	  mesothelioma.	  These	  minerals	  also	   increase	  the	  risk	  of	  autoimmune	  diseases.	  Regarding	  air	  pollution,	  it	  is	  well	  established	  that	  inhaled	  particles	   can	   have	   adverse	   health	   effects,	   such	   as	   cardiovascular	   diseases	   or	  respiratory	  illnesses.	  However,	  the	  health	  effects	  due	  to	  particle	  inhalation	  vary	  greatly	   with	   the	   type	   of	   particles	   that	   are	   present	   in	   the	   air.	   The	   field	   of	  nanotoxicology,	  where	   the	   toxic	  properties	  of	  nanomaterials	   are	   assessed,	   first	  emerged	   when	   nanomaterials	   were	   already	   used	   in	   industrial	   processes	   and	  products.9	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The	  development	  of	  novel	  nanomaterials	  has	  been	  growing	  exponentially	  and	  it	  is	  not	  possible,	  or	  even	  reasonable,	  to	  fully	  characterize	  the	  toxic	  effects	  of	  all	  emerging	   materials.	   One	   strategy	   to	   overcome	   this	   problem	   is	   to	   extensively	  characterize	   a	   selection	   of	   common	   types	   of	   nanomaterials	   in	   order	   to	   define	  structure-­‐activity	   relationships	   that	   in	   turn	   may	   be	   used	   to	   predict	   the	  properties	   of	   similar	  materials.	   The	   knowledge	   obtained	   on	   ultrafine	   particles	  (<100	  nm)	  of	  dust	  and	  air	  pollutants	  provides	  a	  starting	  point	  to	  predict	  possible	  health	   effects	   of	   engineered	   nanomaterials.10,	   11	   The	   major	   challenge	   when	  addressing	   the	   toxic	   properties	   of	   nanomaterials	   compared	   to	   chemical	  compounds	   is	   that	   there	   are	   many	   more	   variables	   to	   consider.	   Relevant	  nanoparticle	   descriptors	   include:	   size,	   shape,	   charge,	   coating,	   concentration,	  roughness,	   agglomeration,	   aggregation	   and	   composition	   (Figure	   1).	   These	  various	  properties	  distinguish	  nanotoxicology	  from	  classical	  toxicology,	  where	  a	  mass	  based	  dose-­‐metric	  is	  used.	  	  	  
	  Figure	  1.	  Overview	  of	  physico-­‐chemical	  descriptors	  of	  nanomaterials.	  	   To	  further	  characterize	  nanomaterials,	   it	   is	  of	  great	  importance	  to	  learn	  how	  such	  materials	   interact	  with	   living	   systems.	   It	   has	  been	   shown	   that	  nano-­‐sized	  materials	  can	  translocate	  across	  cell	  membranes,	  and	  reach	  the	  cytoplasm,	  either	  through	   active	   or	   passive	   mechanisms.	   In	   fact,	   nanoparticles	   have	   even	   been	  reported	  to	  enter	  the	  cell	  nucleus.12	  Nanoparticles	  for	  drug	  delivery	  often	  need	  to	  overcome	  different	  biological	   barriers,	  e.g.	  mucus	   layers	  or	   cell	  membranes,	   to	  reach	   their	   intended	   target.	   On	   the	   other	   hand,	   nanomaterials	   that	   are	  engineered	   for	  other	  purposes	  may	  cause	  negative	  effects	   if	   taken	  up	  by	  a	  cell.	  For	   the	  nanoparticle	   to	  enter	   the	  cell,	   it	  must	  pass	   the	  plasma	  membrane.	  This	  biological	   barrier,	  which	   is	   very	   efficient	   and	   complex,	   encapsulates	   the	  whole	  cell	  and	  partition	  the	  intracellular	  environment	  from	  the	  extracellular.	  The	  core	  structure	  of	   the	  plasma	  membrane	   is	   the	  phospholipid	  bilayer,	  a	  structure	   that	  consists	   of	   amphiphilic	   lipid	   molecules.	   Apart	   from	   the	   outer	   cell	   membrane,	  many	  intracellular	  organells,	  e.g.	  mitochondria	  and	  nucleus,	  are	  also	  confined	  by	  a	   phospholipid	   bilayer.	   The	   cell	   membrane	   control	   intracellular	   homeostasis	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through	   selective	   transport	   mechanisms	   across	   the	  membrane,	   processes	   that	  are	  essential	   for	   cell	   survival.	  Because	  of	   this,	   the	   cell	  membrane	   is	   a	   sensitive	  target	   for	   possible	   effects	   of	   nanoparticles.	   The	   cell	   membrane	   is	   further	  described	  in	  Chapter	  4	  together	  with	  common	  model	  systems	  thereof.	  In	  order	  to	  fully	  exploit	  the	  benefits	  of	  nanomaterials	  in	  a	  responsible	  way,	  it	  is	   of	   great	   interest	   to	   better	   understand	   in	   what	   way	   different	   nanomaterials	  interact	  with	  biological	  barriers,	  specifically	  the	  cell	  membrane.13-­‐15	   	  One	  of	  the	  strategies	  chosen	  in	  this	  thesis	  is	  to	  use	  a	  well	  defined	  model	  system	  of	  the	  native	  cell	  membrane	  (see	  further	  Chapter	  4).	  Other	  researchers	  have	  also	  adopted	  the	  use	  of	  model	  systems	  of	  the	  cell	  membrane	  to	  investigate	  their	  interactions	  with	  nanomaterials.13,	   15-­‐17	   There	   are	   different	   approaches	   to	   engineer	   membrane	  model	  systems,	  and	  plain	  lipid	  bilayers	  are	  attractive	  due	  to	  their	  low	  degree	  of	  complexity.18	  Lipid	  membranes	  are	  readily	  formed,	  from	  dispersed	  liposomes,	  on	  hydrophilic	  supports	  such	  as	  SiO2.19	  Supported	  lipid	  membranes	  can	  be	  studied	  by	   a	   variety	   of	   different	   surface	   sensitive	   analytical	   techniques.16,	   20	   The	  analytical	   techniques	   used	   in	   this	   work	   are	   described	   in	   Chapter	   5.	   A	   second	  strategy	  to	  address	  cell	  membrane	  interactions	  was	  used	  to	  assess	  nanoparticle	  interactions	  with	  complex	  model	  systems,	  i.e.	  living	  cells,	  and	  to	  probe	  direct	  or	  indirect	  effects	  of	  nanomaterial	  exposure.	  	  
1.1 Aim of thesis The	  aim	  of	  the	  work	  presented	  in	  this	  thesis	  has	  been	  to	  establish	  a	  platform	  for	   in	  depth	   studies	  of	   the	  nano-­‐bio	   interface	  using	   surface	   sensitive	  analytical	  techniques.	   The	   two	   main	   foci	   have	   been	   to	   study	   the	   interactions	   between	  various	   nanomaterials	   and	   (i)	   well	   defined	   supported	   lipid	   membranes	  (schematically	  illustrated	  in	  Figure	  2),	  or	  (ii)	  living	  cells	  using	  acoustic	  sensing.	  	  	  
	  Figure	  2.	  Shematic	  illustration	  of	  a	  nanoparticle	  approaching	  a	  supported	  lipid	  membrane	  consisting	  of	  two	  types	  of	  lipid	  molecules.	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2 
Nanomaterials 
2.1 Definition The	  prefix	  “nano”,	  which	  originate	  from	  the	  Greek	  “nanos”	  signifying	  “dwarf”,	  has	   become	   a	   very	   popular	   label	   within	   science.	   Words	   like	   nanoantenna,	  nanoporous	   and	   nanoarrays	   have	   become	   common	   in	   the	   scientific	   literature	  although	  they	  are	  not	  widely	  established.	  However,	  more	  and	  more	  nano	  words	  enter	   the	   dictionaries.	   At	   present	   the	   words	   nanometer,	   nanosecond,	   and	  nanotechnology	  are	  included	  in	  the	  Swedish	  Academy	  Dictionary.	  Nano	  denotes	  one	   billionth	   (10-­‐9),	   i.e.	   one	   nanometer	   (nm)	   is	   one	   billionth	   of	   a	   meter.	   In	  newspaper	  reporting	  the	  use	  of	  “nano”	  is	  common.	  In	  a	  recent	  linguistic	  analysis	  of	  Swedish	  newspaper	  articles,	  covering	  a	  22-­‐year	  period,	  close	  to	  400	  different	  words	  containing	  “nano”	  were	  identified.21	  For	  the	  purpose	  of	  safety	  regulation	  and	  legislation	  it	  is	  of	  great	  importance	  to	  define	  what	  should	  be	  classified	  as	  a	  nanomaterial.	  It	  has	  become	  evident,	  due	  to	  the	  ongoing	  global	  debate,	  that	  it	  is	  not	  a	  trivial	  task	  to	  come	  up	  with	  a	  definition	  that	   captures	   all	   nanomaterials.	   Often	   a	   nanomaterial	   is	   defined	   as	   a	  material	  with	   at	   least	   one	   dimension	   in	   the	   range	   of	   1-­‐1000	   nm.	   However,	   in	   other	  definitions	  the	  size	  of	  at	  least	  one	  dimension	  is	  limited	  to	  1-­‐100	  nm.	  This	  smaller	  limit	  is	  motivated	  by	  changes	  in	  physical	  properties	  of	  some	  materials	  that	  occur	  when	   reaching	   this	   size	   regime.	   For	   example,	   the	   surface	   atoms	   of	   nano-­‐sized	  particles	   have	   less	   neighbors	   and	   hence	   a	   lower	   binding	   energy	   compared	   to	  atoms	   in	   the	  bulk	  material,	   this	   results	   in	   a	   lower	  melting	   temperature	   for	   the	  nanoparticles.22	  Thus,	  it	  has	  been	  argued	  that	  rather	  than	  basing	  a	  definition	  on	  size,	  it	  should	  be	  based	  on	  changes	  in	  material	  physical	  properties.	  	  In	  October	  2011	  the	  European	  commission	  adopted	  a	  recommendation	  of	  the	  definition	   of	   a	   nanomaterial.23	   According	   to	   that	   definition	   a	   nanomaterial	  means:	  	  
"A	  natural,	  incidental	  or	  manufactured	  material	  containing	  particles,	  in	  an	  
unbound	  state	  or	  as	  an	  aggregate	  or	  as	  an	  agglomerate	  and	  where,	  for	  50	  %	  or	  
more	  of	  the	  particles	  in	  the	  number	  size	  distribution,	  one	  or	  more	  external	  
dimensions	  is	  in	  the	  size	  range	  1	  nm-­‐100	  nm.”	  
	  
“In	  specific	  cases	  and	  where	  warranted	  by	  concerns	  for	  the	  environment,	  health,	  
safety	  or	  competitiveness	  the	  number	  size	  distribution	  threshold	  of	  50	  %	  may	  be	  
replaced	  by	  a	  threshold	  between	  1	  and	  50	  %.”	  	  In	  December	  2014	   this	  definition	  will	  be	   reviewed,	   focusing	  on	  whether	   the	  given	   number	   size	   distribution	   threshold	   should	   be	   increased	   or	   decreased.	  Similarly,	   in	   nanomedicine,	   it	   is	   important	   to	   define	   the	   field	   and	   what	   a	  nanomedicine	   is.	   One	   could	   claim	   that	   most	   common	   medicines	   are	  nanomedicines	   since	   small	   molecules	   and	   proteins	   are	   in	   the	   nanometer	   size	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range.	  Again,	  there	  exist	  many	  different	  definitions.	  One	  of	  them	  is	  given	  by	  the	  European	  Technology	  Platform	  on	  nanomedicine	  and	  reads	  as	  follows.24	  	  
“Nanomedicine	  is	  the	  application	  of	  nanotechnology	  to	  health.	  It	  exploits	  the	  
improved	  and	  often	  novel	  physical,	  chemical,	  and	  biological	  properties	  of	  materials	  
at	  the	  nanometric	  scale.”	  	  In	   the	   given	   definition	   size	   dimensions	   of	   1-­‐1000	   nm	   are	   included.	   One	  motivation	   for	   this	   is	   that	   in	   the	   area	   of	   medicine,	   nanotechnology	   is	   used	   to	  interact	  with	  cells	  and	  tissues.	  For	  this	  purpose	  materials	  larger	  than	  1-­‐100	  nm	  is	  utilized.24	  
2.2 Occurrence As	   was	   already	   mentioned	   in	   the	   introduction,	   nanomaterials	   have	   always	  been	  around	  since	  there	  are	  several	  natural	  sources	  of	   these	  materials.	  Natural	  sources	  that	  produce	  large	  quantities	  of	  particles,	  and	  have	  the	  potential	  to	  affect	  tremendously	   large	   areas,	   are	   dust	   storms,	   forest	   fires,	   and	   volcano	   eruptions.	  These	   events	   generate	   high	   concentrations	   of	   particulate	   matter	   (including	  nanoparticles)	   that	   may	   cause	   adverse	   health	   effects.	   Another	   major	   natural	  source	  of	  nanoparticles	  are	   the	   seas	  and	  oceans	  across	   the	  world.	  When	  water	  evaporates	   and	  when	  waves	   generate	  water	   drops	   in	   the	   atmosphere,	   sea	   salt	  aerosols	  are	   formed.	  The	  sizes	  of	   these	  particles	  range	   from	  100	  nm	  to	  several	  microns.	  However,	   there	   are	  no	   adverse	  health	   effects	   associated	  with	   sea	   salt	  aerosols.1	  In	   addition	   to	   the	   natural	   sources,	   anthropogenic	   nanomaterials	   constitute	  another	  major	  source.	  Nanomaterials	  are	  created	  in	  combustion	  processes,	  of	  e.g.	  fuel	   and	   coal,	   as	  well	   as	   in	   the	   chemical	   industry.	   Such	   by-­‐products	   of	   human	  activities	   have	   been	  present	   for	   a	   very	   long	   time.	  When	   it	   comes	   to	   deliberate	  production	  and	  use	  of	  nanomaterials	  the	  number	  of	  produced	  nanoparticle	  types	  and	  applications	  areas	  have	  increased	  tremendously	  the	  last	  decades.	  However,	  already	  the	  Romans	  used	  metal	  nanoparticles	  to	  color	  glass.	  One	  famous	  example	  is	  the	  Lycurgus	  cup	  that	  was	  made	  in	  the	  4th	  century.25	  Today	  nanomaterials	  are	  commonly	   used	   in	  many	   commercial	   products	   including	   cosmetics,	  medicines,	  clothing,	  sporting	  goods,	  tires,	  and	  sunscreens.	  Although	  the	  number	  of	  products	  is	   rapidly	   increasing,	   there	   are	   attempts	   to	   make	   an	   inventory	   of	   all	  nanotechnology-­‐based	   products	   on	   the	   market.26	   In	   the	   studies	   that	   form	   the	  basis	   of	   this	   thesis,	   a	   few	   selected	   nanomaterials	   have	   been	   included.	   These	  materials,	   apart	   from	   the	   drug	   carriers,	   are	   described	   in	   some	   detail	   in	   the	  following	   subchapters.	   Nanoparticle-­‐based	   drug	   delivery,	   including	   polymeric	  drug	  carries,	  is	  described	  in	  Chapter	  3.	  	  
2.2.1 Graphene oxide In	   recent	   years,	   after	   the	   observation	   and	   characterization	   of	   exfoliated	  graphene	  by	  Novoselov	  et.	  al.	  in	  200427,	  graphene	  based	  materials	  have	  become	  an	   intense	   area	   of	   research	   and	   the	   materials	   are	   explored	   for	   numerous	  applications.28,	  29	  Materials	  based	  on	  graphene	   include,	   in	  addition	   to	  graphene	  itself,	   graphene	   oxide,	   carbon	   nanotubes	   and	   fullerenes.	   These	   materials	   may	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also	  be	  functionalized	  to	  further	  tune	  their	  properties.	  One	  strategy	  is	  to	  combine	  the	   extraordinary	   properties	   of	   graphene	   and	   its	   derivatives	   with	   other	  materials	   in	   composites.30	   Materials	   that	   successfully	   have	   been	   used	   in	  graphene	  based	  composites	   include,	   for	  example,	   inorganic	  nanostructures31-­‐33,	  polymers34	   and	   biomolecules35.	   Applications	   of	   such	   composites	   include	  batteries33,	   supercapacitors32,	   photovoltaic	   devices31,	   and	   sensing	   platforms35.	  Due	   to	   the	   increasing	  use	  of	   these	  materials	   it	  was	  of	   great	   interest	   to	   study	  a	  graphene	   based	   material	   with	   respect	   to	   its	   lipid	   membrane	   interactions.	  Graphene	   is	   a	   hydrophobic	   material	   and	   needs	   to	   be	   functionalized	   with	  hydrophilic	   groups	   to	   be	   soluble	   in	   aqueous	   environments.	   Hence,	   in	   our	  experiments	  we	  chose	   to	  work	  with	  graphene	  oxide	  due	  to	   its	  water	  solubility.	  Simplistically,	   graphene	   oxide	   is	   a	   graphene	   sheet	   with	   hydroxyl,	   and	   epoxy	  functional	   groups	   on	   the	   basal	   plane	   of	   the	   sheet.	   Carbonyl	   groups	   are	   also	  present,	   mainly	   as	   carboxylic	   acids	   along	   the	   border	   of	   the	   sheet.	   These	  functional	  groups	  can	  be	  seen	  as	  reactive	  handles	  that	  may	  be	  used	  to	  produce	  functionalized	  graphene	  based	  materials.	  The	  most	  common	  route	  to	  produce	  large	  quantities	  of	  graphene	  oxide	  begins	  with	   the	   oxidation	   of	   graphite	   to	   graphite	   oxide.	   In	   this	   process,	   the	   sp2-­‐hybridaziation	  structure	  of	  the	  stacked	  graphene	  sheets	  in	  graphite	  is	  converted	  to	  sp3.	  This	  conversion	  makes	  the	  atomic	  structure	  of	  graphene	  oxide	  distorted	  resulting	   in	   an	   increased	   surface	   roughness.	   Hence,	   the	   oxidation	   process	  increases	   the	   distance	   between	   the	   stacked	   sheets	   of	   graphene	   oxide.	   This	  process	  also	   facilitates	  delamination	  of	   graphite	  oxide	   into	   individual	   sheets	  of	  graphene	   oxide	   by	   sonication.29	   The	   thickness	   of	   a	   graphene	   oxide	  monolayer	  has	   been	  determined	  by	  AFM	   to	   1.6	   nm.	  However,	   due	   to	   the	   intrinsic	   surface	  roughness,	   the	   thickness	   of	   bi-­‐	   and	   trilayers	   are	   2.6	   nm	   and	   3.6	   nm	  respectively.36	  Although	  oxidized	  graphene	   is	   an	   insulator	   it	   is	  possible	   reduce	  the	   material	   to	   restore	   the	   electrical	   properties.	   For	   the	   production	   of	   large	  quantities	   of	   graphene	   from	   graphene	   oxide	   there	   is	   a	   need	   to	   develop	   a	  reduction	  method	  that	  minimizes	  the	  residual	  oxygen	  content.	  	  
2.2.2 TiO2 nanoparticles TiO2	   is	   commonly	   used	   as	   a	   nanomaterial	   due	   to	   its	   many	   important	  application	   areas,	  e.g.	   photocatalysis37,	  38,	  water	  purification39	   and	   solar	   energy	  conversion40.	  In	  addition,	  due	  to	  the	  high	  refractive	  index	  of	  TiO2,	  it	  is	  often	  used	  as	  a	  white	  pigment	  in	  paints	  and	  other	  commercial	  products.41	  It	  should	  be	  noted	  that	  the	  white	  color	  is	  obtained	  from	  larger	  TiO2	  NPs	  or	  agglomerates	  of	  smaller	  ones.	  If	  the	  size	  of	  the	  NPs	  is	  reduced,	  the	  color	  is	  lost.	  TiO2	  NPs	  have	  the	  ability	  to	  absorb	  and	  block	  ultraviolet	  light,	  a	  property	  that	  is	  utilized	  in	  sunscreens.	  In	  recent	  years,	  the	  size	  of	  the	  TiO2	  NPs	  in	  sunscreens	  has	  been	  reduced	  to	  obtain	  a	  transparent	   layer	  when	  applied	   to	   the	  skin.	  Since	  sunscreens	  often	  are	  applied	  before	   bathing	   or	   swimming	   they	   are	   a	   significant	   source	   of	   TiO2	   NP	  contamination	   to	   the	  water	   compartment.	   Naturally,	   due	   to	   the	   photocatalytic	  properties	   of	   TiO2,	   the	   NPs	   used	   in	   sunscreens	   are	   coated	   with	   a	   different	  material,	   usually	   SiO2,	   Al2O3,	   or	   ZrO2.42	   Potential	   emissions	   of	   TiO2	   NPs	   from	  sunscreens,	  and	  other	  sources,	  has	  been	  conducted	  using	  particle	  flow	  analysis.43	  	  There	   exist	   three	   different	   crystal	   structures	   of	   TiO2,	   namely	   brookite,	  anatase,	  and	  rutile.	  These	  structures	  have	  different	  properties.44	  Due	  to	  the	  many	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applications	  and	   large	  production	  volume	  TiO2	  nanoparticles	   is	   included	   in	   the	  OECD	  list	  of	  nanomaterials	  to	  be	  thoroughly	  evaluated	  (see	  section	  2.3.1).	  
2.2.3 SiO2 nanoparticles As	  early	  as	   in	   the	  1860s,	  Thomas	  Graham	  prepared	  silica	  colloids.	  However,	  the	   silica	   technology	  proceeded	   slowly	   and	   the	   early	   silica	   sols	   (colloidal	   silica	  dispersed	  in	   liquid)	  were	  only	  produced	  at	   low	  concentrations,	  were	  not	  stable	  over	  time,	  and	  did	  not	  have	  reproducible	  properties.45	  It	  took	  almost	  a	  century	  to	  overcome	  these	  issues	  and	  to	  develop	  production	  methods	  of	  silica	  sols	  for	  use	  in	  commercial	  products.	  Today	  colloidal	   silica	   is	  produced	   in	   large	  quantities	  and	  used	  in	  numerous	  applications,	  where	  the	  use	  as	  retention	  aid	  in	  papermaking	  is	  likely	  the	  largest.	  In	  papermaking,	  a	  slurry	  of	  pulp	  is	  turned	  into	  a	  solid	  sheet	  of	  paper	   through	   a	   dewatering	   process	   where	   the	   cellulose	   fibers	   need	   to	   be	  retained	  in	  the	  paper.	  The	  efficiency	  of	  this	  process	  is	  significantly	  increased	  by	  the	   use	   of	   colloidal	   silica	   together	   with	   charged	   polymers	   as	   a	   retention	   aid.	  Another	   large	  application	  of	   colloidal	   silica	   is	   the	  use	  as	   an	  additive	   to	   cement	  and	   concrete.	  By	   addition	  of	   silica	  nanoparticles,	   the	   cement	  hardens	   very	   fast	  due	   to	   a	   rapid	   consumption	   of	   the	   available	  water.	   This	   process	   increases	   the	  strength	  of	  the	  final	  product.	  Additionally,	  SiO2	  nanoparticles	  are	  also	  used	  in	  e.g.	  coatings,	   solid	  electrolytes,	  and	  polishing	  agents.45	  For	   the	  same	  reasons	  as	   for	  TiO2	  nanoparticles,	  i.e.	  the	  many	  areas	  of	  applications	  and	  the	  current	  large	  scale	  production	   volumes,	   SiO2	   nanoparticles	   are	   also	   included	   in	   the	   OECD	   list	   of	  nanomaterials	  to	  be	  thoroughly	  evaluated	  (see	  section	  2.3.1).	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2.3 Activities for risk assessment When	   discussing	   risk	   assessment	   it	   is	   important	   to	   be	   aware	   of	   the	   related	  concepts	  hazard,	   exposure	  and	   risk.	  The	  hazard,	   of	   the	  material	   in	   this	   case,	   is	  related	  to	  the	  intrinsic	  properties	  that	  may	  cause	  an	  adverse	  effect.	  Exposure	  is	  a	  measure	  of	  to	  what	  extent	  a	  hazard	  is	  present,	  while	  risk	  (=	  hazard	  x	  exposure)	  is	  the	  probability	  for	  an	  adverse	  effect	  to	  occur	  (Figure	  3).	  In	  the	  following	  sections,	  the	  activities	  for	  the	  risk	  assessment	  of	  nanomaterials	  within	  OECD	  and	  EU	  are	  described.	  	  
	  Figure	  3.	  Risk	  =	  hazard	  x	  exposure	  
2.3.1 OECD OECD	   is	   an	   intergovernmental	   organization	   with	   representatives	   from	   34	  developed	   countries	   in	   Europe	   (including	   Sweden),	   North	   and	   South	   America,	  Asia	   and	   the	   Pacific	   region.	   In	   addition	   to	   these	   countries,	   the	   European	  Commission	   is	   also	   represented	   in	   OECD.	   In	   this	   organization	   the	   member	  countries	  discuss	  issues	  of	  mutual	  concern,	  co-­‐ordinate	  policies	  and	  respond	  to	  international	   problems	   in	   a	   unified	   manner.	   In	   September	   2006,	   the	   OECD	  council	  established	  the	  Working	  Party	  on	  Manufactured	  Nanomaterials	  (WPMN)	  to	  address	  the	  implication	  of	  manufactured	  nanomaterials	  on	  the	  human	  health	  and	   the	   environmental	   safety.	   	   This	   working	   party	   aims	   to	   ensure	   that	   the	  approach	   to	   hazard,	   exposure	   and	   risk	   assessment	   of	   manufactured	  nanomaterials	   is	   of	   an	   internationally	   harmonized	   standard.	   WPMN	   bring	  together	  more	   than	  100	  experts,	   partly	   from	  OECD	  member	   countries	  but	   also	  from	  non-­‐member	  countries	  and	   international	  organizations.	  To	  address	   issues	  regarding	  manufactured	  nanomaterials	  WPMN	  heads	  the	  following	  projects.46	  	  
• OECD	  database	  on	  manufactured	  nanomaterials	  to	  inform	  and	  analyze	  EHS	  (environment,	  health	  and	  safety)	  research	  activities.	  
• Safety	  testing	  of	  a	  representative	  set	  of	  manufactured	  nanomaterials.	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• Manufactured	  nanomaterials	  and	  test	  guidelines.	  
• Co-­‐operation	  on	  voluntary	  schemes	  and	  regulatory	  programs	  
• Co-­‐operation	  on	  risk	  assessment	  
• The	  role	  of	  alternative	  methods	  in	  nanotoxicology	  
• Exposure	  measurement	  and	  exposure	  mitigation	  
• Environmentally	  sustainable	  use	  of	  manufactured	  nanomaterials	  	  One	  of	   these	  projects	   involves	  safety	  testing	  of	  manufactured	  nanomaterials.	  In	   this	   project	   a	   representative	   set	   of	   manufactured	   nanomaterials	   has	   been	  chosen	   and	   all	   materials	   will	   be	   thoroughly	   investigated.	   The	   concept	   of	   this	  project	   is	   that	   testing	   a	   certain	   set	   of	   nanomaterials	   can	  derive	  much	   valuable	  information	  regarding	  the	  safety	  of	  nanomaterials	  in	  general	  and	  the	  assessment	  methods.	   In	   this	   way,	   the	   understanding	   of	   what	   intrinsic	   properties	   of	   the	  nanomaterials	   that	   affects	   the	   human	   health	   and	   the	   environment	   may	   be	  significantly	   increased.	  The	  project	   is	   implemented	  in	  two	  stages.	  First,	  a	   list	  of	  representative	  manufactured	  nanomaterials	  and	  a	  specific	  set	  of	  endpoints	  were	  agreed	   upon.	   The	   nanomaterials	   that	   were	   selected	   (Figure	   4)	   are	   all	   on	   the	  market	  or	  close	  to	  be	  introduced	  on	  the	  market.47	  	  
	  Figure	  4.	  The	  manufactured	  nanomaterials	  selected	  by	  WPMN.	  The	  table	  of	  nanomaterials	  should	  be	   viewed	   as	   a	   “snapshot	   in	   time”	   as	  materials	   could	   be	   added	   or	   removed	   depending	   on	   the	  current	  use	  and	  production	  of	  nanomaterials.	  	  In	   the	   second	   stage,	   the	   OECD	   Sponsorship	   Program	   for	   the	   Testing	   of	  Manufactured	  Nanomaterials	   has	   been	   launched.	   In	   this	   program,	   the	   selected	  nanomaterials	  will	   be	   tested	  with	   respect	   to	   human	  health	   and	   environmental	  safety.	  For	  each	  of	   the	   included	  nanomaterials	  about	  60	  pre-­‐decided	  endpoints	  should	  be	  determined.	  The	  selected	  endpoints	  belong	  to	  the	  following	  areas.47	  	  
• Nanomaterial	  information/identification	  (9	  endpoints)	  
• Physical-­‐chemical	  properties	  and	  material	  characterization	  (17	  endpoints)	  
• Environmental	  fate	  (15	  endpoints)	  
• Environmental	  toxicology	  (6	  endpints)	  
• Mammalian	  toxicology	  (9	  endpoints)	  
• Material	  safety	  (3	  endpoints)	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For	   each	  nanomaterial	   to	   be	   tested,	   a	   lead	   sponsor,	   i.e.	   one	   of	   the	   countries	  involved	   in	   WPMN,	   is	   responsible	   for	   conducting	   or	   coordinating	   the	   tests	  necessary	   to	  determine	   the	  endpoints.	  For	  some	  nanomaterials,	   there	   is	  a	   joint	  lead	   sponsorship.	   The	   process	   of	   conducting	   the	   tests	   is	   in	   progress	   and	   will	  most	  likely	  last	  for	  several	  years	  ahead.	  	  
2.3.2 EU The	   EU	   policy	   on	   the	   development	   of	   nanotechnologies	   is	   that	   it	   should	   be	  “integrated,	   safe	   and	   responsible”.48	   This	   standpoint	   includes	   reviewing	   and	  adapting	  EU	   laws,	  monitoring	  safety	   issues	  and	   to	  be	  engaged	   in	  dialogue	  with	  national	   authorities	   and	  other	   stakeholders.	   In	   the	  European	   commission	   (EC),	  which	   is	  one	  of	   the	  main	   institutions	  within	   the	  EU,	   there	  are	  several	  activities	  regarding	   nanotechnology.	   These	   activities	   are	   distributed	   among	   different	  departments	  (DGs,	  Directorates-­‐General)	  dealing	  with	  policies	   in	  various	  areas,	  
e.g.,	   health	   and	   consumers,	   research,	   education,	   or	   environment.	   An	   important	  task	   for	   the	  EC	  has	  been,	   and	   still	   is,	   to	   dedicate	  EU	   research	   funding	   to	   areas	  addressing	   safety	   aspects	   of	   nanotechnologies.	   Under	   the	   sixth	   and	   seventh	  framework	   programme	   (FP	   6	   and	   FP7),	   thirty	   research	   projects	   regarding	   the	  safety	   of	   nanomaterials,	   with	   a	   total	   founding	   of	   80	   million	   EURO,	   was	  included.49	   To	   maximize	   the	   synergy	   between	   these	   project	   the	   European	  Nanosaftey	   Cluster	   has	   been	   formed.	   The	   EC	   also	   supply	   knowledge	   to	  international	  bodies	  working	  with	  related	  risk	  assessment,	  e.g.	  the	  OECD.	  In	   2004	   there	   was	   a	   communication	   from	   the	   EC	   entitled	   “Towards	   a	  European	   strategy	   for	   nanotechnology”.48	   In	   this	   communication,	   the	   need	   to	  identify	  and	  address	  safety	  concerns	  (both	  real	  and	  perceived)	  at	  an	  early	  stage,	  is	   highlighted.	   The	   following	   year,	   an	   action	   plan	   for	   Europe	   regarding	  nanosciences	  and	  nanotechnologies	  was	  adopted.50	  One	  of	  the	  main	  areas	  in	  this	  action	  plan	  regards	  the	  safety	  aspects	  of	  nanomaterials.	  Later,	  the	  action	  plan	  has	  been	   followed	  up	  with	   two	   implementation	  reports,	   in	  which	   the	  progress	  was	  reported.51,	  52	  To	  ensure	  that	  sufficient	  information	  regarding	  the	  hazards	  of	  chemical	  substances	  is	  available,	  the	  REACH	  (Registration,	  Evaluation,	  Authorization	  and	  Restriction	  of	  Chemical	  substances)	  regulation	  was	  adopted	  in	  2007.	  By	  the	  means	  of	  REACH,	  the	  human	  health	  and	  the	  environment	  will	  be	  better	  protected	  since	  the	  intrinsic	  properties	  of	  substances	  will	  be	  identified	  at	  an	  early	  stage.	  According	  the	  REACH	  regulation,	  there	  is	  a	  great	  responsibility	  of	  the	  industry	  to	  provide	  safety	  information	  on	  the	  substances	  they	  manufacture	  or	  use.	  This	  information	  must	  be	  reported	  to	  the	  European	  Chemicals	  Agency	  (ECHA)	  where	  it	  is	  stored	  in	  a	  central	  database.	  However,	  although	  nanomaterials	  are	  covered	  by	  the	  definition	  of	  substances	  in	  REACH,	  the	  regulation	  is	  not	  well	  adapted	  to	  such	  materials.	  The	  main	  reasons	  for	  this	  being	  that	  only	  substances	  produced	  in	  quantities	  of	  more	  than	  one	  tonne	  per	  year	  need	  to	  be	  registered	  and	  a	  chemical	  safety	  report	  must	  be	  produced	  when	  the	  quantities	  exceed	  10	  tonnes	  per	  year.53	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3 
Nanoparticle-based drug delivery The	   merging	   of	   nanotechnology	   and	   medicine	   is	   commonly	   referred	   to	   as	  Nanomedicine.54	   It	   is	   a	   rapidly	   expanding	   field	   of	   research	   including	   many	  different	  applications,	  such	  as	  drug	  delivery	  systems55,	  contrast	  agents	  for	  in	  vivo	  imaging56,	  sensor	  platforms	  for	  in	  vitro	  diagnostics57,	  as	  well	  as	  medical	  implants	  and	   scaffolds	   for	   tissue	   engineering58.	   The	   expectations	   on	   the	   field	   of	  Nanomedicine	   are	   high	   in	   terms	   of	   e.g.	   improved	   therapies	   and	   diagnostics.	  However,	   nanotechnology	   is	   often	   associated	   with	   unrealistic	   futuristic	  scenarios.	   For	   example,	   in	   Michael	   Crichton´s	   novel	   Prey	   nanorobots	   develop	  their	  own	  intelligence	  and	  become	  a	  large	  threat.	  For	  this	  reason	  it	  is	  important	  to	   distinguish	   between	   the	   objectives	   that	   could	   be	   realized	   for	   the	   benefit	   of	  common	   health	   within	   a	   reasonable	   timescale	   and	   plain	   fiction.	   The	   great	  potential	   of	   this	   area	   arises	   from	   the	   fact	   that	   the	   length	   scale	   of	   the	  nanomaterials	  coincides	  with	  the	  length	  scale	  of	  the	  smallest	  functional	  entity	  in	  the	  cell,	  the	  proteins.	  The	  engineering	  of	  functional	  materials	  in	  the	  nano	  scale	  is	  predicted	  not	   only	   to	  provide	   a	  more	   effective	   interaction	  with	   living	   cells	   but	  also	   to	   reach	   intracellular	   targets.	   For	   this	   purpose,	   nanomedicines	   need	   to	  compromise	   biological	   barriers,	   processes	   that	   may	   give	   rise	   to	   unexpected	  toxicities.	   Because	   of	   this,	   it	   is	   also	   of	   great	   importance	   to	   assess	   the	   safety	   of	  nano-­‐sized	  drug	  carriers.49	  
3.1 Nanoformulations for increased bioavailability  Many	  of	  the	  applications	  within	  Nanomedicine	  are	  based	  on	  the	  use	  of	  nano-­‐sized	   particles.59	   For	   example,	   NPs	   are	   designed	   as	   drug	   carriers	   to	   protect,	  target,	  and	  release	  an	  active	  substance	  at	  the	  target	  site,	  thus	  minimizing	  adverse	  systemic	  effects.60	  The	  bioavailability	  of	  the	  drug,	  i.e.	  the	  fraction	  of	  the	  delivered	  dose	   that	   reaches	   the	   circulation	   system,	  depends	  on	   the	   specific	  properties	  of	  the	   drug	   and	   the	   chosen	   route	   of	   administration.	   There	   are	   several	   different	  routes	   to	   administer	   drugs,	   e.g.	   orally,	   pulmonary,	   or	   by	   injections.	   Some	   are	  more	  convenient	  than	  others	  and	  because	  of	  this	  they	  are	  more	  often	  preferred.	  By	   the	  use	  of	  drug	  carriers	   it	  could	  potentially	  be	  possible	   to	  alter	   the	  route	  of	  administration	   when	   developing	   new	   formulations.	   It	   is	   also	   preferred	   to	  administer	  the	  smallest	  possible	  dose	  to	  obtain	  the	  desired	  effect	  since	  the	  risk	  of	  adverse	  side	  effects	  is	  decreased.	  By	  targeted	  drug	  delivery,	  a	  local	  high	  dose	  of	  the	  drug	  at	  its	  intended	  site	  of	  action	  can	  be	  reached	  while	  healthy	  tissues	  in	  other	  areas	  of	  the	  body	  are	  exposed	  at	  lower	  concentrations.	  This	  lowers	  the	  risk	  of	  adverse	  side	  effects	  tremendously.	  An	  additional	  advantage	  of	  small	  doses	   is	  that	   drug	   molecules	   in	   general	   and	   biopharmaceuticals	   in	   particular,	   are	  expensive	   to	  prepare.	   If	  only	  a	  small	  amount	  of	   the	  drug	  were	  needed	   the	  cost	  could	  be	  kept	  low.	  	  Human	   insulin,	   a	   hormone	   that	   removes	   excess	   glucose	   from	   the	  blood	   and	  that	  is	  used	  in	  the	  treatment	  of	  diabetes	  mellitus,	  is	  a	  common	  model	  protein	  in	  the	  development	  of	  NP	  formulations.	  When	  formulating	  this	  hormone,	  the	  aim	  is	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to	   reach	   a	   high	   bioavailability	   using	   non-­‐parental	   routes	   of	   administration.	  Ideally,	  the	  outcome	  of	  research	  performed	  on	  NP	  formulations	  of	  human	  insulin	  could	   be	   used	   when	   formulating	   other	   biomolecular	   drug	  molecules.	   Diabetes	  mellitus	  is	  a	  family	  of	  diseases	  in	  which	  the	  blood	  glucose	  levels	  are	  too	  high.	  It	  is	  a	  chronic	  condition	  that	  affects	  a	  tremendous	  number	  of	  people	  worldwide	  every	  year.	  Since	  insulin	  was	  first	  extracted	  from	  the	  pancreas	  in	  1921	  by	  Banting	  and	  Best,	   huge	   efforts	   have	   been	  made	   to	   administer	   the	   hormone	   in	   a	   convenient	  way	   for	   the	   treatment	   of	   the	   disease.	   The	   most	   common	   way	   to	   administer	  insulin	  is	  through	  subcutaneous	  injections	  and	  despite	  the	  inconvenience	  for	  the	  patients,	  no	  alternative	  routes	  of	  administrations	  have	  been	  successful	  so	  far.	  As	  early	  as	   in	  1924	   the	   first	  studies	  on	   inhaled	   insulin	  were	  published61	   and	  since	  then	   pulmonary	   and	   other	   non-­‐parental	   routes	   of	   administration,	   such	   as	  transdermal,	  nasal,	  oral,	  and	  rectal	  have	  been	  investigated.62,	  63	  In	  January	  2006,	  Exubera®,	   an	   advanced	   method	   by	   Pfizer/Nektar	   Therapeutics	   based	   on	  recombinant	  insulin	  for	  inhalation,	  was	  approved	  by	  both	  the	  European	  and	  the	  American	  drug	  agencies	  (EMEA	  and	  FDA).	  Although	  it	  was	  the	  first	  product	  of	  its	  kind	   on	   the	   market	   it	   was	   withdrawn	   in	   October	   2007	   due	   to	   low	   market	  acceptance.64	  Other	  devices	   for	   inhaled	   insulin	  has	   reached	  phase	   III	   in	   clinical	  trials.	   One	   such	   product	   was	   AERx®	   iDMS	   developed	   by	   Aradigm	   Corporation	  and	  Novo	  Nordisk.	  However,	  Novo	  Nordisk	  stopped	  all	  investigations	  on	  inhaled	  insulin	  shortly	  after	  Pfizer	  announced	  that	  Exubera®	  was	  being	  withdrawn	  from	  the	   market.	   Due	   to	   the	   ease	   of	   administration	   and	   patient	   compliance,	   oral	  delivery	  of	  human	  insulin	  has	  also	  gained	   large	   focus.	  Materials	   that	  have	  been	  used	   to	   formulate	   insulin	   for	   oral	   delivery	   include	   polymeric	   hydrogels65,	  polymeric	   solid	   nanoparticles66	   and	   liposomes67.	   Polyelectrolyte	   complexes	  (PECs)	   have	   also	   been	   prepared	   for	   non-­‐invasive	   insulin	   delivery.68-­‐70	   In	   this	  work	   several	   different	   insulin	   loaded	   PECs	   have	   been	   studied	   with	   respect	   to	  their	  lipid	  membrane	  interactions.	  
3.2 Nanoparticle designs for passive and active targeting Nanoparticulate	   drug	   formulations	   have	   various	   degree	   of	   functionalization	  depending	   on	   the	   drug	   to	   be	   administered	   and	   the	   chosen	   route	   of	  administration.	   With	   respect	   to	   their	   functionalities,	   drug	   carriers	   are	   often	  referred	  to	  as	  the	  first,	  second	  or	  third	  generation.	  A	  construct	  prepared	  from	  a	  plain	  nano	  sized	  carrier	  and	  a	  drug,	  is	  referred	  to	  as	  the	  first	  generation	  of	  NPs	  for	   drug	   delivery	   (Figure	   5A).	   In	   more	   advanced	   designs,	   the	   nanodrug	   is	  functionalized	  with	  a	  targeting	  entity	  (Figure	  5B	  and	  C).	  This	  entity	  is	  commonly	  an	   antibody,	   part	   of	   an	   antibody,	   a	   peptide,	   or	   an	   aptamer.	   The	   targeting	  molecules	  then	  direct	  the	  drug	  to	  a	  specific	  organ	  or	  a	  cell	  type	  that	  express	  the	  ligand	   to	   the	   targeting	   molecule	   on	   the	   cell	   surface.	   For	   example,	   tumor	  biomarkers	   such	   as	   epidermal	   growth	   factor	   (EGF)	   receptors	   have	   been	  successfully	  targeted	  in	  cancer	  treatments.71	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Figure	   5.	   The	   first,	   second,	   and	   third	   generation	   of	   drug	   carriers.	   (A)	   The	   first	   generation	  consists	   of	   a	   carrier	   and	   its	   drug	   load.	   (B)	   The	   second	   generation	   the	   drug	   carriers	   are	  functionalized,	   e.g.	   with	   shielding	   and/or	   targeting	   entities.	   (C)	   The	   third	   generation	   drug	  carriers	  contain	  several	  payloads	  with	  different	  targets.	  	  When	  targeting	  solid	  tumors	  it	  is	  possible	  to	  reach	  a	  high	  local	  concentration	  of	   NPs	   in	   the	   tumor	   without	   a	   specific	   targeting	  moiety,	   due	   to	   the	   enhanced	  permeability	  and	  retention	  (EPR)	  effect.	  The	  EPR	  effect	  relates	  to	  the	  leakiness	  of	  the	  vascular	  tumor	  tissue,72	  and	  provides	  a	  mechanism	  for	  passive	  targeting.	  The	  targeting	   of	   the	   drug	   to	   the	   diseased	   tissue	   rather	   than	   having	   an	   even	  distribution	   it	   in	  the	  entire	  body	   increases	  the	  efficacy	  of	   the	  drug	  and	  reduces	  the	   risk	   of	   adverse	   side	   effects.	   At	   the	   site	   of	   action,	   the	   release	   of	   the	   active	  substance	   could	   either	   be	   passive	   or	   initiated	   by	   different	   methodologies	  depending	  on	  the	  nature	  of	  the	  NP.	  An	  active	  drug	  release	  could	  be	  achieved	  by	  heating	  absorbing	  particles	  through	  irradiation	  with	  ultrasound	  or	  light73	  (which	  could	  also	  be	   the	  actual	   therapy)	  or	  by	  enzymatic	   cleavage74.	   In	   the	   latter	   case	  the	  carrier	  must	  be	  engineered	  so	  that	  it	  dissociates	  or	  releases	  the	  drug	  in	  any	  other	  way	  as	  a	  response	  to	  a	  specific	  enzyme	  present	  at	   the	  target	  site.	  A	  third	  approach	  to	  an	  active	  drug	  release	  is	  to	  use	  the	  local	  environment	  in	  tumors	  as	  a	  trigger,	  since	  tumor	  tissue	  normally	  has	  a	  lower	  pH	  compared	  to	  healthy	  tissue.75	  	  When	  the	  particle	  is	  functionalized	  with	  a	  targeting	  molecule	  and/or	  an	  active	  release	  mechanism	  they	  are	  referred	  to	  as	  the	  second	  generation	  of	  NPs	  for	  drug	  delivery	   (Figure	   5B).	   The	  NPs	   could	   also	   be	   functionalized	   in	   additional	  ways.	  For	  example,	  it	  has	  been	  shown	  that	  pegylation	  of	  NPs	  can	  significantly	  prolong	  their	   residence	   time	  within	   the	  bloodstream	   (a	  necessary	   step	   in	   the	  direction	  towards	   so	   called	   stealth	   drugs).76,	   77	   In	   this	   way,	   the	   foreign	   material	   is	  protected	   from	   opsonization	   and	   further	   elimination/degradation	   by	   the	  reticuloendothelial	  system	  (RES).	  When	  toxic	  substances	  are	  to	  be	  delivered,	  the	  body	  should	  be	  protected	  from	  the	  substance	  in	  a	  similar	  manner.	  	  Even	  more	  advanced	  approaches	  aim	  at	  multifunctional	  particles	   combining	  therapy	  and	  diagnostics	  (theranostics),	  such	  as	  magnetic	  particles	  which	  can	  be	  used	   both	   as	   contrast	   agents	   in	   MR	   imaging,	   and	   local	   treatment	   by	   the	  application	  of	  an	  external	  magnetic	   field.	  NPs	  which	  belong	  to	  the	  third	  and,	  so	  far,	   most	   advanced	   generation	   of	   NPs	   for	   drug	   delivery	   have	   the	   ability	   to	  overcome	  multiple	  biological	  barriers	   (Figure	  5C).	  For	  example,	  particles	  could	  have	  multiple	  payloads	  where	  the	  first	  payload	  that	  is	  released	  at	  the	  target	  site	  is	  a	  NP	  that	  in	  turn	  carries	  the	  active	  substance	  further	  in	  to	  the	  diseased	  tissue.	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3.1 Common classes of nanoparticles for drug delivery Typical	   NP	   drug	   carrier	   systems	   include	   polymeric	   materials,	   inorganic	  materials	   and	   liposomes.60	   Size,	   shape	   and	   surface	   chemistry	   of	   the	   NPs	   are	  important	  components	  to	  design	  their	  biological	  properties.	  The	  main	  challenge	  when	  designing	  a	  carrier	  for	  biopharmaceuticals	  is	  to	  formulate	  the	  drug	  load	  in	  a	  proper	  way.	  The	  drug	  has	   to	  be	   stable	  when	   it	   is	   attached	   to	   the	   carrier	  and	  active	  when	   it	   is	   released.	   In	   the	   following,	   a	   few	   common	   classes	   on	  NPs	   are	  highlighted.	  
3.1.1 Liposomes In	   a	   liposome	   both	   hydrophilic	   and	   hydrophobic	   environments	   are	   present	  which	   enable	   loading	   of	   drugs	   with	   totally	   different	   properties.	   Hydrophilic	  drugs	   could	   be	   loaded	   in	   the	   closed	   compartment	   inside	   the	   liposome	   and	  hydrophobic	   drugs	   in	   the	   interior	   of	   the	   lipid	   bilayer.	   Liposomes	   are	   the	  most	  common	  nanocarrier	   formulations	  used	   in	  clinic	   today.	  Liposomal	  Doxorubicin,	  which	   is	   used	   to	   treat	   Kaposi´s	   sarcoma,	   metastatic	   breast	   cancer,	   advanced	  ovarian	  cancer,	  and	  multiple	  myeloma,	  was	  among	  the	  first	  NP	  formulations	  on	  the	  market.	  The	  advantage	  of	  delivering	  the	  Doxorubicin	  in	  liposomes	  instead	  of	  as	   a	   pure	   drug	   is	   evident	   when	   looking	   at	   the	   circulation	   half-­‐life.	   Free	  Doxorubicin	   has	   a	   half	   life	   of	   0.2	   h	   in	   the	   circulation	   system	   but	   this	   time	  increases	   to	   2.5	   and	   55	   h	   if	   the	   drug	   is	   administered	   in	   an	   unpegylated	   or	   a	  pegylated	   liposome	   respectively.78	   Furthermore,	   by	   using	   liposomes	   as	   drug	  carriers	  an	  active	  drug	  release	  can	  be	  achieved	  at	   inflamed	  or	  cancerous	  tissue	  due	  to	  the	  enhanced	  activity	  of	  the	  secretory	  phosphlipase	  A2	  (PLA2).74	  
3.1.2 Polymeric nanoparticles There	  are	  many	  types	  of	  NPs	  based	  on	  organic	  polymers.79	  Polymeric	  micelles,	  polymeric	   vesicles	   and	   dendrimers	   are	   some	   of	   the	   main	   groups.	   Another	  commonly	  used	  type	  of	  polymeric	  NP	  is	  polyelectrolyte	  complexes	  (PECs)	  which	  are	   created	   by	   mixing	   oppositely	   charged	   polyions,	   where	   one	   is	   the	  biopharmaceutical	   to	   be	   administered	   (Figure	   6).	   PECs	   form	   spontaneously	  when	   the	   components	   are	   mixed	   and	   are	   mainly	   held	   together	   by	   strong	  electrostatic	   interactions.	   However,	   other	   interaction	   forces	   like	   hydrogen	  bonding,	   hydrophobic	   interactions	   and	   van	   der	   Waals	   forces	   complement	   the	  electrostatic	   interactions	   in	   PEC	   formation.80	   Physical	   properties	   like	  hydrodynamic	   diameter,	   zeta	   potential,	   and	   polydispersity	   of	   the	   PECs	   are	  dependent	   on	   concentration,	   ionic	   strength,	   pH,	   and	   properties	   of	   the	   used	  polymers.	  Major	   advantages	   of	   using	  PECs	   for	   drug	  delivery	  purposes	   are	   that	  they	  have	  a	  slow	  rate	  of	  degradation,	  are	  prepared	  in	  water	  solutions,	  and	  do	  not	  alter	  normal	  cell	  function.80	  Polycationic	  polymers	  have	  been	  widely	  explored	  for	  the	   use	   in	   PEC	   drug	   delivery	   systems	   since	   DNA,	   RNA,	   and	  most	   proteins	   are	  negatively	  charged	  at	  physiological	  conditions.	  Polymers	  commonly	  used	  in	  such	  drug	  delivery	  systems	  include	  biopolymers	  e.g.	  alginate68	  and	  chitosan68,	  81-­‐83	  but	  also	   synthetic	   polymers	   e.g.	   poly(dimethylaminoethyl	   methacrylate)84	   and	  poly(amido	   amine)s	   (PAAs)85.	   In	   this	   work	   several	   different	   PECs	   have	   been	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studied.	   These	   particles	   have	   been	   developed	   for	   non-­‐invasive	   (e.g.	   oral,	  pulmonary,	  or	  nasal)	  administration	  of	  human	  insulin.	  
 
	  Figure	  6.	  Self-­‐assembly	  formation	  of	  a	  PEC	  consisting	  of	  a	  positively	  charged	  polymer	  and	  a	  negatively	  charged	  protein	  (Paper	  II).	  
3.1.3 Magnetic nanoparticles Magnetic	   NPs	   can	   be	   used	   for	   many	   different	   medical	   applications.	   Due	   to	  their	   magnetic	   properties	   they	   can	   be	   used	   as	   contrast	   agents	   for	   magnetic	  resonance	  imaging	  (MRI)	  or	  for	  magnetic	  separation	  purposes,	  but	  also	  to	  induce	  hyperthermia	  or	  as	  guidable	  drug	  carriers.	  The	  particles	  are	  most	  often	  made	  of	  iron	   oxide,	   magnetite	   (Fe3O4)	   or	   maghemite	   (γ-­‐Fe2O3)	   and	   show	   magnetic	  properties	  only	  when	  exposed	  to	  a	  magnetic	   field.	  When	  used	  as	  drug	  carriers,	  magnetic	  NPs	  can	  be	  concentrated	  at	  the	  target	  site	  by	  a	  magnetic	  field.	  Either	  a	  permanent	  magnet	   is	   implanted	   into	   the	   tissue	  or	  an	  external	  magnetic	   field	   is	  applied.	  For	  the	  magnetic	  NPs	  to	  be	  attracted	  by	  a	  magnetic	  field	  it	  is	  important	  that	   they	   are	   big	   enough.	   Too	   small	   particles	   (10-­‐15	   nm)	   are	   hard	   to	   attract	  towards	  the	  blood	  flow.	  Other	  parameters	  that	  determine	  the	  movement	  of	  the	  NPs	  are	  the	  magnetic	  field	  strength	  and	  its	  gradient.	  Apart	  from	  being	  guided	  to	  the	  diseased	  tissue,	  the	  magnetic	  NPs	  can	  be	  visualized	  (diagnostics)	  and	  heated	  by	  an	  alternating	  magnetic	  field	  to	  induce	  hyperthermia	  or	  promote	  drug	  release	  (therapy).86, 87 	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4 
The cell membrane – a biological 
interface  
4.1 Biological barriers and uptake of nanoparticles A	  physical	  barrier	  that	  protects	  the	  internal	  environment	  from	  the	  external	  confines	  all	  living	  entities.	  	  For	  example,	  the	  largest	  human	  organ,	  the	  skin,	  guards	  our	  internal	  organs,	  muscles,	  bones,	  ligaments,	  etc.,	  as	  it	  constitutes	  a	  barrier	  to	  the	  surroundings.	  Apart	  from	  protection,	  the	  skin	  has	  many	  other	  important	  functions	  including	  sensation	  and	  heat	  regulation.	  Similarly,	  the	  cells	  that	  our	  bodies	  are	  composed	  of	  are	  confined	  by	  a	  cell	  membrane.	  In	  the	  following	  sections	  the	  native	  cell	  membrane	  is	  described	  in	  some	  detail.	  In	  addition,	  the	  main	  processes	  in	  which	  NPs	  may	  pass	  this	  biological	  barrier	  and	  reach	  the	  intracellular	  space	  are	  introduced.	  	  
4.1.1 The cell membrane The	  cell	  membrane	  is	  a	  fluid,	  semi	  permeable	  barrier	  surrounding	  the	  cell	  and	  separating	   the	   intracellular	   space	   from	   the	   extracellular	   environment.	   In	   a	   cell	  membrane,	  lipid	  molecules	  are	  arranged	  in	  a	  two–layered	  shell	  (a	  bilayer)	  where	  the	   hydrophobic	   parts	   are	   facing	   each	   other	   in	   the	   interior	   of	   the	   membrane	  whereas	   the	   hydrophilic	   parts	   are	   exposed	   to	   the	   surroundings.	   See	   the	   next	  section	  for	  more	  information	  regarding	  the	  lipid	  molecule.	  The	  same	  structure	  is	  also	   found	   in	  many	   intracellular	   compartments	   (organelles)	  where	   it	   serves	   to	  separate	   these	   compartments	   from	   the	   cytoplasm,	   e.g.	   the	   cell	   nucleus,	   the	  mitochondria,	   the	  golgi	  apparatus,	   the	  endoplasmatic	  reticulum,	   the	  endosome,	  and	  the	  lysosome.	  	  Although	   the	   structure	   of	   the	   cell	   membrane	   is	   based	   on	   phospholipid	  molecules	   it	   also	   contains	   other	   molecules	   like	   proteins,	   glycoproteins,	  cholesterol	  and	  glycolipids.	  The	  amount	  of	  protein	  associated	  with	  a	  membrane	  differs	  between	  different	  cell	   types	  and	  organelles,	  although	  the	  typical	  protein	  content	  is	  about	  50	  %	  by	  mass.88	  The	  lipid	  membrane	  is	  often	  described	  by	  the	  fluid	  mosaic	  model	   which	  was	   introduced	   in	   the	   early	   1970´s	   where	   the	   lipid	  molecules	   and	   the	   associated	   proteins	   are	   allowed	   to	   diffuse	   freely	  within	   the	  membrane.89	  Although	   the	   fluid	  mosaic	  model	   still	   holds	   in	  many	   respects,	   the	  complexity	  of	  the	  cell	  membrane	  is	  today	  believed	  to	  be	  much	  greater.90	  The	  cell	  membrane	   contains	   a	   large	   number	   of	   different	   lipid	   molecules	   that	   in	   some	  areas	   are	   heterogeneously	   distributed	   within	   the	   membrane,	   i.e.	   the	   cell	  membrane	   contains	   domains	  with	   different	   lipid	   compositions.	   These	   domains	  (sometimes	   referred	   to	   as	   rafts)	   could	   possibly	   be	   functional	   since	   their	  properties,	   e.g.	   with	   respect	   to	   lipid	   packing,	   are	   altered	   compared	   to	   the	  surrounding	  membrane.91	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Proteins	  associated	  to	  the	  cell	  membrane,	  integral	  and	  peripheral,	  allow	  the	  cell	  membrane	   to	   carry	   out	   a	   wide	   variety	   of	   different	   functions.	   These	   include	  transporting	   nutrients	   into	   the	   cell	   and	   waste	   products	   out,	   pump	   ions	   or	  molecules	   against	   concentration	   gradients	   to	   keep	   a	   proper	   pH	   and	   osmotic	  pressure	   inside	   the	   cell,	   form	   strong	   connections	   between	  neighboring	   cells	   to	  strengthen	   tissues	   and	   create	   anchoring	   points	   for	   the	   cytoskeleton	   to	  strengthen	   the	   cells.	   Another	   very	   important	   task	   is	   carried	   out	   by	   the	  membrane	   bound	   receptors	   that	   mediate	   signals	   from	   the	   surroundings,	   by	  binding	  signaling	  molecules	  (hormones	  or	  growth	  factors),	  to	  the	  cytosol	  leading	  to	  various	  cellular	   responses.	  As	   the	  membrane	  proteins	  play	  a	  key	   role	   in	   the	  cell	   by	   sensing	   the	   external	   environment	   they	   are	   important	   drug	   targets	   and	  much	  effort	  is	  put	  into	  studying	  this	  class	  of	  proteins.	  About	  50%	  of	  the	  drugs	  on	  the	  market	  target	  membrane	  proteins.92	  Due	  to	  the	  complexity	  of	  the	  native	  cell	  membrane,	  model	  systems	  are	  commonly	  used	  to	  study	  its	  properties.	  
4.1.2 The lipid molecule Eukaryotic	   cells	   have	   a	   tremendously	   complex	   lipid	   repertoire	   consisting	   of	  thousands	   of	   different	   kind	   of	   lipids.93	   Although	   specific	   functions	   have	   been	  assigned	  to	  certain	  lipids,	  there	  are	  likely	  much	  more	  to	  learn	  when	  it	  comes	  to	  lipid	  molecules.	  Lipids	  have	  three	  main	  functions	  in	  eukaryotic	  cells.	  First,	  lipids	  are	   used	   to	   store	   energy,	   mainly	   as	   triacylglycerol	   and	   steryl	   esters.	   These	  reserves	   (lipid	   droplets)	   are	   also	   used	   for	  membrane	   biogenesis.	   Second,	   lipid	  molecules	  are	  the	  core	  component	  in	  cell	  membranes.	  The	  most	  common	  type	  of	  lipid	   in	   eukaryotic	   cell	   membranes	   is	   the	   glycerophospholipid	  phosphatidylcholine	  (PC).	  I	  accounts	  for	  >	  50%	  of	  the	  lipids	  in	  such	  membranes.	  Last,	   lipids	   function	   as	   first	   or	   second	   messengers	   in	   signaling	   transduction	  pathways.94	  Lipids	  are	  amphiphilic	  molecules	  meaning	  that	  they	  are	  polar	  (hydrophilic)	  on	  one	  side	  and	  apolar	  (hydrophobic)	  on	  the	  other.	  Due	  to	  the	  hydrophobic	  effect,	  entropically	   driven	   by	   water,	   lipids	   self-­‐assemble	   in	   aqueous	   solutions	   into	  larger	   structures.	   Depending	   on	   the	   molecular	   features	   of	   the	   lipids	   these	  structures	  are	  either	  micelles,	  inverted	  micells,	  liposomes	  or	  planar	  bilayer	  discs.	  In	   this	   work,	   four	   different	   types	   of	   phospholipids	   have	   been	   used	   to	   form	  model	   membranes;	   these	   are	   1-­‐palmitoyl-­‐2-­‐oleyl-­‐sn-­‐glycero-­‐3-­‐phosphocholine	  (POPC),	  1-­‐palmitoyl-­‐2-­‐oleyl-­‐sn-­‐glycero-­‐3-­‐phospho-­‐L-­‐serine	  (POPS),	  1-­‐palmitoyl-­‐2-­‐oleoyl-­‐sn-­‐glycero-­‐3-­‐phosphoglycerol	   (POPG)	   and	   1-­‐palmitoyl-­‐2-­‐oleyl-­‐sn-­‐glycero-­‐3-­‐ethylphosphocholine	  (POEPC)	  (Figure	  7).	  POPC,	  POPS	  and	  POPG	  occur	  naturally	   in	   cell	  membranes,	  while	  POEPC	   is	  produced	   synthetically.	   POPC	   is	   a	  zwitterionic	  lipid	  with	  a	  net	  neutral	  charge.	  POPS	  and	  POPG	  hold	  a	  net	  negative	  and	   while	   POEPC	   hold	   a	   positive	   charge.	   Synthetic	   cationic	   lipids,	   e.g.	   POEPC,	  with	   various	   hydrophobic	   and	   hydrophilic	   regions	   have	   been	   developed	   for	  liposomal	   gene	  delivery.	   In	   lipoplexes,	   complexes	  between	   lipid	   structures	  and	  nucleic	   acids	   (e.g.	   DNA),	   electrostatic	   interactions	   play	   an	   important	   part.95	  Because	  of	  this,	  cationic	  lipids	  are	  needed	  to	  attract	  the	  polyanionic	  nucleic	  acids.	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Figure	  7.	  Chemical	  structures	  of	  the	  four	  different	  lipid	  molecules	  used	  in	  this	  work.	  	  By	  selecting	  these	  four	  types	  of	  phospholipids	  it	  was	  possible	  to	  produce	  SLBs	  with	   different	   charge.	   The	   complexity	   of	   the	   resulting	   SLBs	  was	   of	   course	   low	  compared	   to	  native	  cell	  membranes,	  which	   to	  a	   large	  extent	  also	  contain	  other	  components.	  
4.1.3 Cellular uptake of nanoparticles When	  studying	  cellular	  effect	  of	  nanomaterials	  an	  important	  question	  is	  if	  the	  cells	   take	   up	   these	  materials.	   In	   nanomedicine	   it	   is	   often	   required,	   apart	   from	  targeting	  the	  drug	  carrying	  NP	  to	  the	  diseased	  tissue,	  that	  the	  NP	  and/or	  its	  drug	  load	  enters	  the	  cell	  to	  reach	  a	  therapeutic	  effect.	  From	  a	  risk	  perspective	  it	  is	  also	  important	   to	   learn	   where	   the	   nanomaterials	   go	   upon	   cellular	   exposure.	   The	  dominating	   process	   in	   which	   particles	   are	   taken	   up	   by	   a	   cell	   is	   called	  endocytosis.96	  This	  process	  of	  cellular	  entry	  can	  be	  divided	  in	  three	  main	  parts.	  First,	  the	  NP	  is	  engulfed	  by	  the	  cell	  membrane	  forming	  membrane	  invaginations	  that	   in	   turn	   are	   released	   into	   the	   interior	   of	   the	   cell	   forming	   an	   endosome.	  Second,	   the	   endosomes	   are	   delivered	   to	   intracellular	   structures	   that	   enable	  sorting	  of	  the	  NPs	  to	  their	  final	  destinations.	  Last,	  the	  NPs	  are	  delivered	  either	  to	  various	   intracellular	   compartments,	   back	   to	   the	   extracellular	   environment,	   or	  through	   the	   cell	   (transcytosis).	   Another	   way	   that	   NPs	   can	   pass	   the	   epithelial	  lining,	   from	   the	   apical	   to	   the	   basolateral	   side,	   is	   in	   between	   neighboring	   cells	  (paracellular	  transport,	  Figure	  8A).	  One	  important	  physical	  property	  of	  NPs,	  that	  is	  a	  determinant	   for	  the	   fate	  of	   the	  endosome,	   is	   the	  charge.	   It	  has	  been	  shown	  that	  cationic	  biodegradable	  polymeric	  NPs	  passed	  through	  MDCK	  epithelial	  cells	  (transcytosis)	  while	  anionic	  particles	  ended	  up	  in	  lysosomes.	  The	  route	  of	  entry	  
	   22	  
into	  the	  cells	  was	  also	  dependent	  on	  the	  cell	   type.97,	  98	  Naturally,	   the	  size	  of	  the	  nanoparticles	   is	   also	   an	   important	   determinant	   of	   cellular	   uptake.	   It	   has	   been	  shown	  that	  spherical	  gold	  particles	  with	  a	  diameter	  of	  50	  nm	  induces	  maximum	  uptake	   in	  HeLa	  cells.99	  This	  result	   is	   in	   line	  with	  studies	  using	  quantum	  dots100	  and	  a	  recent	  theoretical	  study101.	  	  Endosytosis	   is	   divided	   into	   two	   subsections	   called	   phagocytosis	   and	  pinocytosis	   (Figure	   8B).	   While	   phagocytosis	   mainly	   occurs	   in	   specialized	  phagocytes,	   e.g.	   macrophages	   and	   neutrophils,	   pinosytosis	   occurs	   in	   all	   cell	  types.	   Different	   subtypes	   of	   pinocytosis	   are	   often	   classified	   according	   to	   the	  protein	   involved	   in	   the	   process.	   This	   classification	   gives	   rise	   to	   clathrin	  dependent	   and	   clathrin	   independent	   endocytosis.	   Furthermore,	   the	   clathrin	  independent	   pathway	   is	   divided	   into	   caveolae-­‐mediated	   endocytosis,	   caveolae	  and	  clathrin	  independent	  endocytosis	  and	  macropinocytosis.	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4.2 Membrane model systems There	  is	  a	  strong	  need	  of	  better	  understanding	  the	  processes	  taking	  place	  at	  the	  cell	  surface.	  How	  does	  a	  specific	  protein	   interact	  with	   its	  membrane	  bound	  receptor?	   What	   mechanisms	   determine	   the	   way	   a	   foreign	   nano-­‐sized	   particle	  interacts	  with	   a	   cell	  membrane?	  Questions	   like	   these	   are	   hard	   to	   assess	  when	  working	  with	  living	  cells	  due	  to	  the	  complexity	  of	  the	  system.	  By	  using	  a	  model	  system,	   the	   degree	   of	   complexity	   could	   be	   decreased	   tremendously	   and	   the	  interaction	  processes	  could	  be	  studied	  by	  a	  wide	  variety	  of	  analytical	  techniques,	  which	   are	   not	   applicable	   to	   entire	   cells.	   Following	   this	   methodology	   a	   more	  fundamental	   understanding	   of	   the	   interaction	   processes	   is	   gained.	   Common	  membrane	   model	   systems	   include	   liposomes,	   supported	   lipid	   bilayers,	   and	  Langmuir-­‐Blodgett	  films	  (Figure	  9).	  
 
	  Figure	  9.	  Schematic	  images	  of	  common	  membrane	  model	  systems.	  (A)	  liposome,	  (B)	  supported	  lipid	  bilayer	  and	  (C)	  Langmuir-­‐Blodgett	  deposition.	  
4.2.1 Liposomes Liposomes	  are	  spherical	  entities	  that	  consist	  of	  a	  lipid	  bilayer	  shell	  enclosing	  an	   aqueous	   interior.105	   It	   is	   possible	   to	   produce	   liposomes	   in	   a	   wide	   range	   of	  sizes,	   from	   diameters	   of	   a	   few	   tenths	   of	   nanometers	   to	   several	   hundred	  micrometers.	   Often	   liposomes	   are	   referred	   to	   as	   lipid	   vesicles	   and	   classified	  according	   to	   their	   size	   and	   lamellarity.	   This	   classification	   yields	   small	   (SUV),	  large	   (LUV)	   and	   giant	   (GUV)	   unilamellar	   vesicles.	   Although	   several	   different	  techniques	   can	   be	   used	   to	   produce	   unilamellar	   vesicles,	   extrusion	   is	   the	  most	  common.	  In	  this	  technique,	  which	  was	  first	  introduced	  by	  Hope	  et.	  al.	  in	  1985106,	  a	  lipid	  suspension	  is	  pressed	  back	  and	  forth	  through	  a	  polycarbonate	  membrane	  with	  a	  well-­‐defined	  pore	  size.	  Later,	   in	  1991,	  a	  convenient	  device	   for	  extruding	  liposomes	   in	  volumes	  up	   to	  1	  mL	  was	  described	  and	  evaluated.107	  By	  changing	  the	  pore	  size	  of	  the	  membrane	  the	  final	  size	  of	  the	  liposomes	  can	  be	  tuned.	  The	  main	  advantage	  of	  using	  liposomes	  instead	  of	  supported	  lipid	  bilayers	  is	  that	  an	  aqueous	  environment	  is	  present	  on	  both	  sides	  of	  the	  lipid	  bilayer.	  Due	  to	  this	  it	  is	  possible	   to	   incorporate	   large	   transmembrane	   proteins	   in	   their	   native	  conformation	  into	  the	  lipid	  bilayer	  shell	  of	  the	  liposomes.	  However,	  it	  is	  difficult	  to	  probe	   the	   interior	   compartment	  of	   the	   liposome,	  which	  would	  be	  necessary	  for	  measuring	  for	  example	  charge	  translocations	  across	  the	  membrane.	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4.2.2 Supported lipid bilayers In	  this	  work,	  supported	  lipid	  bilayers	  (SLBs)	  were	  used	  as	  a	  model	  system	  for	  the	   native	   cell	   membrane	   and	   are	   here	   described	   in	   more	   detail.	   An	   SLB	   is	  formed	   on	   a	   solid	   support	   (sensor	   surface),	   typically	   coated	   with	   SiO2,	   by	  adsorption	   and	   rupture	   of	   liposomes	   leading	   to	   the	   formation	   of	   an	   extended	  planar	   bilayer.	   The	   rupture	   of	   the	   adsorbed	   liposomes	   is	   for	   most	   lipid	  compositions	   initiated	   at	   a	   certain	   surface	   coverage	   due	   to	   mechanical	   strain	  between	   adjacent	   liposomes.	   The	   initial	   rupture	   of	   liposomes	   form	   patches	   of	  bilayers	   that	   in	   turn	   fuse	   and	   form	   a	   continuous	   SLB.19,	   108,	   109	   SLBs	   could	   be	  formed	  over	   large	  areas	  (in	  the	  order	  of	  cm2)	  and	  are	  fluid	  in	  their	  nature.	  The	  simplest	   SLB	   consist	   of	   only	   one	   type	   of	   lipids.	   From	   this	   starting	   point	   the	  complexity	   could	   be	   increased	   by	   changing	   the	   lipid	   composition	   or	   the	  membrane	  morphology.	  The	  latter	  typically	  occur	  when	  an	  amphiphile	  is	  added	  to	   the	   membrane.110	   Since	   the	   SLB	   is	   placed	   directly	   on	   the	   support,	   only	  separated	   by	   a	   thin	   layer	   of	   water	   molecules,	   the	   incorporation	   of	  transmembrane	  proteins	  is	  difficult.	  These	  proteins	  will	  lose	  their	  mobility	  in	  the	  lipid	   membrane	   and	   their	   function	   due	   to	   the	   close	   proximity	   to	   the	   solid	  support.	  To	  solve	  this	  problem	  the	  SLB	  could	  be	  formed	  on	  a	  polymer	  cushion	  or	  a	   tether	   can	  be	  placed	  between	   the	   surface	  and	   the	  membrane.111-­‐113	   Since	   the	  SLB	  is	  confined	  to	  a	  solid	  support	  a	  variety	  of	  surface	  sensitive	  techniques	  can	  be	  used	   for	   the	  analyses,	  e.g.	  AFM,	  QCM-­‐D	  and	   reflectometry.114,	  115	   In	  Figure	  10	  a	  schematic	  of	  a	  SLB	  on	  a	  QCM-­‐D	  sensor	  surface	  is	  shown.	  	  
	  Figure	  10.	  Schematic	  model	  of	  a	  supported	  lipid	  bilayer	  formed	  on	  a	  QCM-­‐D	  sensor	  surface.	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4.2.3 Langmuir-Blodgett films Another	   commonly	   used	   model	   system	   of	   the	   cell	   membrane	   is	   Langmuir-­‐Blodgett	   (LB)	   films116.	   The	   LB	   technique,	   in	   which	   the	   model	   membrane	   is	  formed,	  can	  be	  divided	  in	  two	  main	  parts.	  First,	  an	  organized	  layer	  of	  amphiphilic	  molecules	  (e.g.	  lipids)	  is	  formed	  at	  an	  air-­‐water	  interface	  (Langmuir	  monolayer)	  and	  second,	  a	  substrate	  is	  vertically	  passed	  through	  the	  interface	  transferring	  the	  Langmuir	  monolayer	  to	  the	  substrate.	  The	  substrate	  can	  be	  passed	  through	  the	  monolayer	   repeatedly,	   and	   for	   each	   pass	   an	   additional	   monolayer	   of	   the	  amphiphilic	  molecules	   is	  added.	   In	   this	  way	   it	   is	  possible	   to	  build	  multilayered	  assemblies	   on	   the	   substrate.	   The	   Langmuir	  monolayer,	   which	   by	   itself	   can	   be	  used	  as	  model	  system	  for	  the	  cell	  surface,	  is	  formed	  inside	  a	  through	  in	  which	  the	  surface	  area	  can	  be	  altered.	  This	  makes	  it	  possible	  to	  alter	  the	  local	  density	  and	  organization	   of	   the	   molecules	   by	   regulating	   the	   lateral	   pressure.	   At	   a	   surface	  pressure	  of	  30	  mN/m	  the	  lipid	  packing	  density	  is	  similar	  to	  a	  cell	  membrane.117	  At	   this	  point,	   drugs	  or	  drug	   loaded	  NPs	   can	  be	  added	   to	   the	   subphase	  and	   the	  change	   in	   surface	   pressure	   can	   be	   studied.15	   Naturally,	   Langmuir	   monolayers	  cannot	  be	  used	  as	  a	  model	  to	  study	  transport	  processes	  across	  a	  cell	  membrane	  since	   it	  only	  consists	  of	  one	   lipid	   layer	  and	   is	   located	  at	  an	  air-­‐water	   interface.	  Despite	  this,	  this	  type	  of	  model	  system	  can	  be	  used	  to	  mimic	  the	  outer	  surface	  of	  a	   cell.	   Other	   advantages	  with	   using	   lipid	  monolayers	   as	   a	  model	   system,	   apart	  from	   the	   possibility	   to	   control	   the	   surface	   pressure,	   are	   that	   the	   lipid	  composition,	  temperature	  and	  subphase	  content	  are	  controlled.118	  As	   mentioned,	   it	   is	   possible	   to	   form	   a	   bilayer	   on	   a	   solid	   support	   from	   the	  Langmuir	  monolayer	  by	   the	  LB	   technique.	  This	   is	  performed	  by	   first	   forming	  a	  lipid	   monolayer	   on	   the	   surface	   of	   the	   subphase	   and	   then	   transferring	   the	  substrate	  first	  downwards	  and	  then	  upwards	  through	  the	  interphase.	  The	  same	  result	   can	   also	   be	   obtained	   by	   a	   combination	   of	   the	   LB	   and	   the	   Langmuir-­‐Schaeffer	   (LS)	   techniques.	   In	   the	   LS	   technique119,	   a	   Langmuir	   monolayer	   is	  formed	   and	   subsequently	   a	   hydrophobic	   substrate	   is	   placed	   horizontal	   to	   the	  subphase	  and	  kept	   in	  contact	  with	  the	  Langmuir	  monolayer	  for	  30-­‐60	  s.	   In	  this	  way	   the	   Langmuir	   monolayer	   is	   transferred	   to	   the	   hydrophobic	   substrate.	   To	  form	  a	   lipid	  bilayer	  with	  a	  combination	  of	   the	   two	   techniques,	   the	   first	   layer	   if	  transferred	  by	  the	  LB	  technique	  and	  the	  second	  by	  the	  LS	  technique.	  
4.3 Forces at the nano-bio interface When	  considering	  the	  forces	  that	  may	  be	  exerted	  between	  nanomaterials	  and	  a	   cell	   membrane	   it	   is	   easy	   to	   realize	   that	   a	   vast	   number	   of	   interactions	   are	  possible.	   As	   a	   starting	   point,	   it	   may	   be	   useful	   to	   consider	   the	   interactions	  between	   colloidal	   particles	   in	   suspension,	   including	   e.g.	   steric,	   electrostatic,	  solvent,	  and	  Van	  der	  Waals	  interactions	  (Figure	  11A).120	  	  To	  obtain	  a	  stable	  NP	  suspension,	  the	  NPs	  are	  commonly	  stabilized	  by	  steric	  or	   electrostatic	   means.	   Steric	   stabilization	   is	   obtained	   by	   functionalizing	   the	  surface	  of	  the	  nanoparticle	  with	  a	  polymer,	  e.g.	  PEG.	  When	  two	  polymer-­‐coated	  surfaces	   approach	   each	   other	   they	   experience	   a	   repulsive	   force	   due	   to	   the	  unfavorable	   entropy	   associated	   with	   the	   confinement	   of	   the	   polymers	   (upon	  compression).	   In	   nanomedicine,	   the	   same	   strategy	   is	   used	   to	   avoid	   plasma	  protein	   adsorption	   on	   the	   surfaces	   of	   drug	   carriers,	   resulting	   in	   a	   decreased	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cellular	  uptake.121	  Electrostatic	  stabilization	  of	  the	  NP	  suspension	  is	  achieved	  for	  NPs	  possessing	  a	  sufficiently	  high	  surface	  charge.	  Charged	  NPs	  of	  the	  same	  type	  will	  be	  kept	  away	  from	  each	  other	  due	  to	  electrostatic	  repulsion.	  In	  suspension,	  the	  surface	  charges	  are	  balanced	  by	  counter	  ions	  in	  the	  solution.	  These	  ions	  form	  an	  electrical	  double-­‐layer	   surrounding	   the	  NPs.	  More	   specifically,	   the	  electrical	  double-­‐layer	  consists	  of	  tightly	  bound	  ions	  close	  to	  the	  surface	  (Stern	  layer)	  and	  more	  loosely	  bound	  ions	  further	  away	  from	  the	  surface	  (diffuse	  layer).	  Generally,	  electrostatic	  interactions	  can	  occur	  over	  a	  long	  range	  (hundreds	  of	  nanometers)	  compared	  to	  other	  types	  of	  interaction	  forces.	  However,	  at	  a	  high	  ionic	  strength,	  
e.g.	   in	   a	   biological	  medium,	   this	   force	   is	   efficiently	   screened	   some	   nanometers	  from	  the	  surface.	  In	   addition	   to	   steric	   and	   electrostatic	   interactions,	   solvation	   is	   another	  important	   phenomenon	   for	   the	   stability	   of	   NPs.	   For	   lyophilic	   materials,	   i.e.	  materials	   that	   have	   an	   affinity	   for	   the	   surrounding	   dispersion	   medium,	   the	  solvent	  molecules	  bind	   strongly	   to	   the	   surface	  of	   the	  nanoparticles	   and	   form	  a	  protective	   layer	   that	   prevent	   particle	   aggregation.	   This	   effect	   is	   referred	   to	   as	  solvation.	  If	  the	  dispersion	  medium	  is	  water,	  the	  same	  effect	  is	  commonly	  called	  the	  hydration	  force.	  Another	   important	   interaction	  between	  NPs	   is	   the	  Van	  der	  Waals	   force.	   This	   force	   originates	   from	   quantum	   mechanical	   fluctuations	   of	  electrons	  in	  the	  material.	  These	  fluctuations	  produce	  a	  dipole	  in	  the	  particle	  that	  in	  turn	  induce	  a	  dipole	  in	  an	  adjacent	  particle.	  The	  Van	  der	  Waals	  force	  between	  similar	  materials	  are	  always	  attractive.122	  The	   interactions	  between	  colloids,	  or	  colloids	  and	  surfaces,	  are	  described	  by	  the	  well-­‐established	  DLVO-­‐theory	  (after	  Derjaguin,	  Landau,	  Verway,	  and	  Overbeek).	  This	   theory	  combines	  the	  repulsive	  electrostatic	   interactions	  and	   the	  attractive	  Van	  der	  Waals	   forces	   and	  makes	   it	  possible	   to	   calculate	   a	   distance	   dependent	   interaction	   potential	   between	   the	  interacting	  entities	  (Figure	  11B).	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The	   studies	   presented	   in	   Paper	   I-­‐IV	   regard	   the	   interactions	   between	  nanomaterials	  and	  SLBs.	  Although	  the	  mentioned	  forces	  still	  apply,	  the	  situation	  is	   somewhat	   different	   in	   such	   systems	   compared	   to	   the	   interactions	   between	  colloids.	  Now,	  two	  different	  entities	  (NP	  and	  SLB),	  with	  fundamentally	  different	  properties	  (shape,	  size,	  composition	  etc.)	  interact	  (Figure	  12).	  In	  the	  studies,	  the	  composition	   of	   the	   supported	   lipid	   bilayer	   was	   varied,	   i.e.	   the	   electrostatic	  interactions	   between	   the	   NP	   and	   SLB	   were	   tuned	   to	   be	   either	   repulsive	   or	  attractive.	   In	   addition,	   the	   fluid	   nature	   of	   the	   lipid	   membrane	   allows	   for	  segregation	  of	  different	  types	  of	   lipid	  molecules	  upon	  NP	  interactions.	   It	   is	  also	  important	  to	  be	  aware	  of	  the	  fact	  that	  the	  lipid	  membrane	  is	  supported	  on	  a	  solid	  substrate,	   which	   may	   have	   an	   impact	   on	   the	   studied	   interactions,	   due	   to	   e.g.	  restricted	   flexibility	   of	   the	  membrane	   or	   induced	   asymmetry	   between	   the	   two	  leaflets.	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Another	   parameter	   that	   is	   important	   to	   consider	   upon	   NP-­‐cell	   membrane	  interactions	   is	   the	   possible	   transformations	   of	   the	   NP	   when	   dispersed	   in	   a	  biological	  medium.124,	  125	  When	  entering	  a	  biological	  medium,	  the	  surface	  of	  the	  NP	   will	   become	   coated	   with	   proteins,	   forming	   a	   protein	   corona.	   This	   process	  shapes	  the	  surface	  properties	  and	  alters	  the	  hydrodynamic	  size	  of	  the	  NP.	  Since	  the	   protein	   corona	   largely	   determines	   the	   cellular	   interactions	   it	   is	   of	   high	  interest	  to	  learn	  how	  the	  protein	  corona	  depends	  on	  the	  particle	  composition.126,	  127	  
4.4 From membrane models towards whole cell analyses Although	   membrane	   model	   systems	   are	   commonly	   used	   as	   cell	   membrane	  mimics,	   it	   is	   not	   straightforward	   to	   predict	   the	   outcome	   of	   in	   vitro	   cell	   assays	  based	   on	   model	   membrane	   experiments.	   However,	   I	   do	   not	   believe	   that	   such	  comparisons	   should	   be	   made,	   at	   least	   not	   until	   proper	   structure	   activity	  relationships	  have	  been	  established.	  Instead,	  the	  two	  types	  of	  analyses	  should	  be	  used	  as	  complement	  to	  each	  other,	  similar	  to	  the	  way	  that	  cell	  testing	  relates	  to	  animal	  studies.	  When	  it	  comes	  to	  studies	  of	  NPs	  using	  cell	  cultures,	  the	  endpoints	  often	  relate	  to	  NP	  induced	  cytotoxicity	  or	  to	  the	  fate	  of	  the	  NPs,	  e.g.,	  uptake	  and	  intracellular	  localization.	  	  There	  exist	  a	  wide	  variety	  of	  cytotoxicity	  assays,	  but	  the	  majority	  relates	  cell	  death	   to	   a	   colorimetric	   output.	   In	   turn,	   these	  methods	   are	   based	  on	   either	   the	  integrity	   of	   the	   plasma	   membrane	   or	   the	   mitochondrial	   activity.128	   If	   the	  integrity	  of	  the	  plasma	  membrane	  is	  compromised	  upon	  NP	  exposure,	  there	  will	  be	   leakage	  of	   intracellular	  contents	   that	  are	  detected	   in	   the	  cytotoxicity	  assays.	  For	  example,	  released	  amount	  of	  lactate	  dehydrogenase	  (LDH)	  is	  proportional	  to	  the	  number	  of	  damaged	  or	  lysed	  cells.129	  It	  is	  also	  possible	  to	  determine	  if	  a	  cell	  is	   alive	   or	   dead	   by	   testing	   the	   mitochondrial	   activity.130	   One	   such	   test	   that	   is	  commonly	  used	  is	  the	  MTT	  viability	  test.	  Furthermore,	  the	  levels	  of	  glutathione	  can	  be	  analyzed	  to	  detect	  oxidative	  stress,	  e.g.,	  lipid	  peroxidation,	  as	  a	  sub-­‐leathal	  cellular	   response	   to	   nanoparticle	   exposure.	   Such	   exposure	   may	   also	   cause	  inflammation,	  which	  could	  be	  tested	  by	  analyzing	  the	  levels	  of	  pro-­‐inflammatory	  cytokines	  and	  proteins,	  e.g.,	  IL-­‐1β,	  IL-­‐6,	  and	  TNF-­‐α.	  The	   use	   of	   surface	   sensitive	   analytical	   techniques	   to	   monitor	   cellular	  responses	   caused	   by	   external	   stimuli,	   such	   as	   NP	   exposure,	   is	   not	   yet	   widely	  acknowledged.	   However,	   when	   it	   comes	   to	   acoustic	   sensors	   their	   use	   in	   cell	  studies	  is	  increasing.	  See	  section	  5.2.1	  for	  further	  information	  regarding	  QCM-­‐D	  and	   cells.	   Surface	   acoustic	   techniques	   may	   be	   used	   to	   probe	   cell-­‐surface	  interactions	  and	   the	  mechanical	  properties	  of	   the	   cell.	   	   In	  both	   these	  areas	   the	  cytoskeleton	  play	  a	  vital	  role.	  The	   cytoskeleton	   of	   eukaryotic	   cells	   is	   composed	   of	   three	   main	   fibrous	  structures:	   actin	   filaments	   (7-­‐9	   nm	   in	   diameter),	   microtubules	   (24	   nm	   in	  diameter),	  and	  intermediate	  filaments	  (10	  nm	  in	  diameter).	  	  These	  structures	  are	  responsible	   for	   supporting	   the	   cell	   membrane	   and	   form	   the	   shape	   of	   the	   cell.	  Unlike	   the	   skeleton	   of	   vertebrates,	   the	   cytoskeleton	   undergoes	   constant	  rearrangements	   that	   may	   generate	   movements	   of	   the	   cell.	   Another	   essential	  function	  of	  primarily	  the	  actin	  filaments	  and	  the	  microtubules	  is	  that	  they	  form	  tracks	   along	  which	  organelles	   can	  move	   in	   the	   cytosol.	  Motor	  proteins	   such	  as	  myosin	   V,	   kinesin,	   and	   dynein	   mediate	   this	   transport.	   One	   example	   of	   rapid,	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synchronous,	   and	   bi-­‐directional	   transport	   of	   organelles	   in	   the	   cytosol	   is	   the	  transport	   of	   pigment	   granules	   (melanosomes)	   in	   melanophores.131	  Melanophores,	   which	   are	   present	   in	   the	   skin	   of	   many	   fish,	   amphibians,	   and	  reptiles,	  are	  involved	  in	  the	  color	  change	  of	  the	  animals	  in	  response	  to	  external	  stimuli.	   Depending	   on	   the	   intracellular	   distribution	   of	   melanosomes	   the	   cells	  appear	   dark	   (dispersed	   state)	   or	   bright	   (aggregated	   state).	   The	   transport	   of	  melanosomes	  can	  be	  triggered	  either	  by	  melanocyte	  stimulating	  hormone	  (MSH)	  or	   melatonin,	   which	   induce	   dispersion	   and	   aggregation	   respectively	   (Figure	  13).132	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5 
Experimental techniques This	  chapter	  gives	  a	  brief	  introduction	  to	  the	  analytical	  techniques	  used	  in	  this	  work.	  Apart	  from	  the	  first	  technique	  (dynamic	  light	  scattering),	  that	  was	  applied	  to	  characterize	  nanoparticles	  in	  bulk,	  all	  techniques	  are	  surface	  based.	  The	  main	  technique	  throughout	  this	  work	  has	  been	  the	  quartz	  crystal	  microbalance	  with	  dissipation	  monitoring	  (QCM-­‐D).	  This	  technique	  has	  been	  complemented	  with	  other	  surface	  sensitive	  techniques,	  e.g.,	  AFM,	  DPI,	  or	  reflectometry,	  depending	  on	  the	  system	  under	  study.	  The	  specific	  application	  where	  QCM-­‐D	  is	  used	  to	  study	  cells	  is	  highlighted	  in	  section	  5.2.1.	  
5.1 Nanoparticle size and zeta potential measurements Dynamic	   Light	   Scattering	   (DLS),	   also	   known	   as	   Photon	   Correlation	  Spectroscopy	  (PCS),	  is	  a	  technique	  that	  is	  used	  to	  determine	  the	  size	  of	  colloidal	  particles	  or	  macromolecules	  in	  solution.137	  The	  technique	  takes	  advantage	  of	  the	  Brownian	   motion	   of	   particles	   in	   solution.	   Brownian	   motion	   is	   a	   stochastic	  process	   due	   to	   collisions	   with	   surrounding	   molecules.	   When	   illuminating	   the	  suspension	  with	  laser	  light,	  the	  light	  will	  be	  scattered	  by	  the	  particles	  and	  due	  to	  the	  Brownian	  motion	  the	  intensity	  of	  the	  scattered	  light	  will	  fluctuate	  over	  time.	  The	   time-­‐dependant	   fluctuation	   is	   measured	   and	   used	   to	   determine	   an	  autocorrelation	   function.	   In	   autocorrelation	   measurements	   the	   signal	   is	  constantly	   compared	   to	   itself	  using	  a	   small	   time	   shift,	   τ.	  The	   correlation	  of	   the	  signal,	  G,	  decays	  exponentially	  and	  the	  rate	  is	  determined	  by	  the	  diffusion	  of	  the	  particles.	  	  ! = ! !!! ! ! + ! !" = ! + !!!!!!!"	  	   (1)	  In	  equation	  1,	  B	  is	  the	  baseline,	  A	  the	  amplitude,	  q	  the	  scattering	  vector	  and	  D	  the	   translational	   diffusion	   coefficient.	   The	   scattering	   vector	   is	   calculated	  according	  to	  equation	  2	  where	  n	   is	   the	  refractive	   index	  of	   the	  solvent,	  λ0	   is	   the	  wavelength	  of	  the	  laser	  in	  vacuum	  and	  θ	  is	  the	  scattering	  angle.	  	  ! = !!"!! !"# !! 	   	   	   	   	   (2)	  By	  measuring	   the	   speed	  of	   the	  Brownian	  motion,	   the	   translational	   diffusion	  coefficient,	  D,	  is	  obtained	  (eq	  1).	  Using	  the	  Stokes-­‐Einstein	  equation	  (eq.	  3),	  this	  diffusion	  coefficient	  can	  be	  used	  to	  calculate	  the	  hydrodynamic	  diameter,	  DH.	  !! = !"!!"#	   	   	   	   	   	   (3)	  In	  equation	  3,	  k	  is	  the	  Boltzmann	  constant,	  T	  is	  the	  temperature	  and	  η	  is	  the	  viscosity	  of	  the	  dispersant.	  If	   the	   sample	   consists	  of	   several	   size	  populations	   it	   is	  possible	   to	  determine	  their	   individual	   sizes	   by	   using	   distribution	   algorithms.138	   However,	   the	   result	  depends	  on	  several	  factors	  such	  as	  the	  relative	  sizes	  of	  the	  different	  populations	  and	  their	  relative	  scattering	  intensity	  as	  well	  as	  their	  polydispersity.	  The	  result	  is	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given	   as	   an	   intensity	   distribution	  where	   the	   percentage	   of	   the	   intensity	   of	   the	  scattered	   light	   is	   shown	   as	   a	   function	   of	   the	   particle	   size.	   This	   data	   could	   be	  recalculated	  to	  a	  number	  distribution.	  Since	  the	  scattering	  intensity	  is	  related	  to	  the	   particle	   diameter	   by	   a	   factor	   of	   106,	   the	   presence	   of	   large	   particles	   will	  dramatically	  influence	  the	  intensity	  distribution	  while	  small	  particles	  will	  have	  a	  much	  smaller	  effect.	  	  	  By	   electrophoretic	   light	   scattering	   it	   is	   possible	   to	   determine	   the	   zeta	  potential	   of	   nanoparticles.	   Around	   a	   charged	   particle	   there	   exist	   layers	   of	  counter	   ions,	   i.e.	   ions	  of	  opposite	  charge.	   In	  the	   inner	   layer,	   the	   ions	  are	  tightly	  associated	  with	  the	  particle	  (Stern	  layer)	  and	  in	  the	  outer	  layer	  the	  ions	  are	  more	  diffusely	   associated.	   Inside	   the	   diffuse	   layer	   there	   is	   a	   boundary	   called	   the	  slipping	  plane.	  Within	  the	  slipping	  plane	  the	  ions	  move	  together	  with	  the	  particle	  as	   a	   stable	   entity	   in	   an	   electric	   field.	   The	   potential	   at	   the	   slipping	   plane	   is	  commonly	  referred	  to	  as	  the	  zeta	  potential	  or	  mean	  surface	  charge.	  To	  determine	  the	  zeta	  potential,	  an	  electric	  field	  is	  applied	  across	  a	  suspension	  of	  the	  particles.	  When	   equilibrium	   between	   the	   electric	   and	   the	   opposing	   frictional	   forces	   is	  reached,	   the	   particles	   are	   travelling	   at	   a	   constant	   velocity	   (electrophoretic	  mobility,	   UE).	   This	   velocity	   is	   measured	   by	   laser	   doppler	   velocimetry.	   The	  electrophoretic	   mobility	   could	   then	   be	   used	   to	   calculate	   the	   zeta	   potential	   by	  using	  the	  Henry	  equation	  (eq.	  4)	  !! = !!"#(!")!! 	   	   	   	   	   (4)	  In	   equation	   4,	   ε	   is	   the	   dielectric	   constant,	   z	   is	   the	   zeta	   potential,	   f(ka)	   is	  Henry´s	   function	   and	  η	   is	   the	   viscosity.	  When	  measurements	   are	  performed	   in	  aqueous	  media	  at	  moderate	  electrolyte	  concentrations,	  Henry´s	  function	  can	  be	  estimated	  to	  1.5	  according	  to	  the	  Smoluchowski	  approximation.	  	  
5.2 QCM-D Quartz	   crystal	   microbalance	   with	   dissipation	   monitoring	   (QCM-­‐D)	   is	   a	  technique	   that	   measures	   small	   mass	   changes	   on	   a	   sensor	   surface,	   and	   the	  viscoelastic	   properties	   of	   the	   attached	  material.	   The	   experimental	   setup	   and	   a	  quartz	   sensor	   are	   shown	   in	   Figure	   14.	   QCM-­‐D	   is	   a	   well	   established	   surface	  sensitive	   technique	  which	   has	   been	   used	   to	   study	   the	   formation	   of	   SLBs108,	  139	  and	   their	   biomolecular	   interactions140.	   The	   sensitivity	   of	   the	   technique	   is	   very	  high	  and	  masses	   in	   the	  order	  of	  ng/cm2	  can	  be	  detected.	  The	  technique	   is	  built	  upon	  a	  piezoelectric	  quartz	  crystal.	  This	  means	  that	  when	  the	  crystal	  is	  subjected	  to	  mechanical	  stress	  electric	  charges	  are	  generated	  on	  its	  surface,	  and	  when	  an	  electric	   field	   is	   applied	   the	   crystal	   is	   strained.	   In	   most	   QCM-­‐D	   setups,	   AT-­‐cut	  quartz	  crystals	  are	  used	  and	  the	  surfaces	  of	  the	  disc	  shaped	  sensors	  are	  covered	  with	  thin	  metal	  electrodes.	  An	  AT-­‐cut	  crystal	  is	  cut	  in	  an	  angle	  of	  35.25°	  from	  its	  optical	   axis	   and	   oscillates	   in	   thickness	   shear	   mode	   when	   subjected	   to	   an	  oscillating	   electric	   field.	   Resonance	   occurs	   when	   the	   frequency	   of	   the	   applied	  field	  corresponds	  to	  the	  fundamental	  frequency	  of	  the	  crystal	  or	  to	  an	  overtone	  thereof.141	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  Figure	   14.	   Photo	   of	   a	   QCM-­‐D	   E4	   setup	   (Q-­‐Sense).	   The	   inset	   shows	   the	   two	   faces	   of	   a	   QCM-­‐D	  sensor.	  To	  the	  left	  is	  the	  upper	  surface	  (sensing	  surface)	  and	  to	  the	  right	  is	  the	  lower	  surface	  that	  connects	  the	  top	  and	  bottom	  electrodes	  to	  the	  instrument.	  
 Mass	   associated	   to	   the	   sensor	   surface	   induces	   a	   decrease	   in	   the	   resonance	  frequency	  (Figure	  15).	  If	  the	  mass	  (macoustic)	  is	  small	  compared	  to	  the	  mass	  of	  the	  crystal,	  evenly	  distributed	  in	  a	  thin	  layer,	  rigidly	  coupled	  and	  does	  not	  slip,	  it	  is	  proportional	   to	   the	   induced	   shift	   in	   frequency	   (Δfz).	   This	   relationship	   is	  described	  by	  the	  Sauerbrey	  relation	  (eq.	  5).142	  !!"#$%&!" = ! ∙ ∆!!! 	  	   	   	   	   (5)	  
C, the mass sensitivity constant, is -17.7 ng/(cm2 Hz) for an AT cut crystal with a 
fundamental frequency of 5 MHz and z (1, 3, 5, 7, 9, 11 or 13) is the number of the 
harmonic. 
 
	  Figure	   15.	   The	   principle	   of	   QCM	   sensing.	   By	   applying	   an	   alternating	   voltage	   across	   the	   sensor	  induces	   oscillations	   of	   the	   quartz	   at	   its	   resonance	   frequency	   (left	   figure).	   When	   mass	   is	  associated	  with	  the	  sensor	  surface	  the	  resonance	  frequency	  decreases	  (right	  figure).	  
 
V V 
	   34	  
In	   non	   rigid	   films,	   shear	   acoustic	   waves	   propagates	   differently	   than	   in	   the	  quartz	  crystal.	  Due	  to	  this,	  the	  crystal	  and	  the	  attached	  film	  cannot	  be	  considered	  as	   one	   unit	   and	   the	   Sauerbrey	   equation	   is	   no	   longer	   valid.	   Apart	   from	   the	  frequency,	   the	  dissipation	   factor	   (D)	   is	  also	  measured	   in	   the	  QCM-­‐D	   technique.	  This	   factor	   derives	   from	   decay	   rate	   of	   the	   voltage	   over	   the	   crystal	   when	   the	  driving	  voltage	  is	  turned	  off	  and	  is	  described	  by	  the	  following	  relation	  (eq.	  6).143	  ! = !!"##"$%&'!!!∙!!"#$%& 	   	   	   	   	   (6)	  Edissipated	  is	  the	  energy	  dissipated	  during	  one	  period	  of	  oscillation	  and	  Estored	  is	  the	  energy	  stored	   in	   the	  oscillating	  system.	  The	  dissipation	   factor	  correlates	   to	  the	   viscoelastic	   properties	   of	   the	   attached	   material,	   very	   rigid	   films	   have	   low	  dissipation	  and	  loosely	  attached	  materials	  generate	  high	  dissipation	  (Figure	  16).	  	  
 
	  Figure	  16.	  The	  principle	  of	  the	  dissipation	  response.	  When	  the	  driving	  voltage	  is	  switched	  off	  the	  oscillations	  of	  the	  sensor	  is	  damped	  as	  energy	  is	  dissipated.	  The	  oscillation	  amplitude	  decreases	  slowly	   in	   the	  case	  of	  a	  bare	  sensor	  surface	  (left	   figure).	   If	  a	  soft	  material	   is	  associated	  with	   the	  sensor	  surface	   the	  damping	  occurs	  rapidly	  (center	   figure).	   In	  a	  more	  rigid	  system	  the	  damping	  occurs	  more	  slowly	  (right	  figure).	  
 The	  oscillatory	  motion	  of	   the	  quartz	   crystal	   generates	   a	   decaying	  wave	   that	  extends	   away	   from	   the	   sensor	   surface.	   How	   long	   the	   wave	   extends,	   i.e.,	   the	  penetration	  depth	  (δ)	  is	  determined	  according	  to	  Equation	  7.144	  ! = !!!"	   	   	   	   	   	   (7)	  where	   η	   is	   the	   shear	   viscosity	   and	   ρ	   the	   density	   of	   the	   medium.	   The	  penetration	   depth	   also	   depends	   on	   ω,	   the	   angular	   frequency	   of	   the	   quartz	  crystal.	  Note	  that	  δ	  is	  proportional	  to	  √η	  and	  to	  1/√f	  (since	  ω=	  2πf),	  where	  f	   is	  the	   resonance	   frequency	   for	   a	   specific	   harmonic	   (e.g.	   5	   MHz).	   At	   room	  temperature	  the	  penetration	  depth	  of	  a	  5	  MHz	  sensor	  in	  water	  is	  about	  250	  nm	  for	  the	  fundamental	  frequency	  (z	  =	  1)	  and	  about	  150	  nm	  for	  the	  third	  harmonic	  (z	  =	  3).	  In	   QCM-­‐D	   instruments	   all	   mass	   associated	   with	   the	   sensor	   surface	   are	  measured,	  not	  only	  the	  “dry”	  mass.	   	  This	  property	  is	  evident	  when	  studying	  the	  formation	   of	   SLBs	   by	   liposome	   rupture.	   First,	   intact	   liposomes	   adsorb	   to	   the	  sensor	   surface	   generating	   large	   shifts	   in	   both	   frequency	   and	   dissipation.	   The	  large	   responses	   are	   due	   to	   the	   floppy	   structure	   on	   the	   surface	   and	   the	   large	  amount	  of	  liquid	  associated	  with	  the	  intact	  liposomes,	  both	  in	  their	  interior	  and	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between	  adjacent	  liposomes.	  	  Second,	  the	  liposomes	  start	  to	  rupture	  and	  release	  the	  enclosed	  liquid	  to	  the	  surroundings,	  a	  process	  that	  lead	  to	  a	  decrease	  in	  the	  frequency	   and	   dissipation	   shifts.	   Finally,	  when	   the	   SLB	   have	   been	   formed,	   the	  frequency	  and	  dissipation	  shifts	  reach	  characteristic	  values	  of	   -­‐26	  Hz	  and	  <	  0.5	  respectively.	  
5.2.1 QCM-D and cells Although	   QCM-­‐D	   is	   commonly	   applied	   in	   studies	   of	   thin	   layers,	   normally	  composed	  of	  a	  low	  number	  of	  components,	  the	  technique	  is	  also	  used	  in	  studies	  of	  cells.	  Within	  the	  last	  decade,	  QCM-­‐D	  (and	  QCM)	  has	  become	  a	  well	  established	  technique	  in	  this	  area	  of	  research	  and	  serve	  as	  a	  good	  complement	  to	  traditional	  microscopy	   analyses.145,	   146	   One	   advantage	   with	   this	   technique	   compared	   to	  microscopy	  is	  that	  it	  averages	  the	  responses	  from	  a	  population	  of	  cells	  and	  is	  not	  subject	  to	  the	  variability	  present	  in	  single	  cells	  analyses.	  Other	  main	  advantages	  with	  QCM-­‐D	  are	  that	  it	  measures	  in	  real	  time	  and	  is	  non-­‐invasive.	  However,	  one	  putative	  effect	  that	  could	  potentially	  affect	  the	  cells´	  ability	  to	  grow	  on	  the	  sensor	  is	  the	  shear	  oscillations	  of	  the	  surface.	  This	  effect	  has	  been	  examined	  and	  it	  was	  shown	   that	   the	   adhesion	   kinetics	   and	   the	   formation	   of	   focal	   adhesion	   points	  were	  only	  affected	  at	  oscillations	  amplitudes	  exceeding	  20	  nm.147	  Typically,	   the	  lateral	  oscillation	  amplitude	  is	  in	  the	  order	  of	  1	  nm,	  hence	  the	  technique	  could	  be	  claimed	  to	  be	  non-­‐invasive.	  The	   main	   research	   areas	   where	   QCM	   is	   applied	   in	   cell	   studies	   include	   cell	  adhesion,	  spreading,	  and	  proliferation.	  In	  such	  studies,	  the	  surface	  properties	  are	  very	   important.	   Often,	   in	   the	   QCM	   experiment,	   the	   substrate	   is	   coated	   with	  serum	  proteins	   (either	   ex	   situ	   or	   in	   situ)	   to	   promote	   cell	   adhesion	   in	   a	   similar	  way	  as	  in	  conventional	  cell	  cultures.	  To	  study	  cell	  adhesion	  in	  further	  detail,	  the	  technique	  may	  be	  used	  to	  evaluate	  functionalized	  sensor	  surfaces.	  For	  example,	  surface	  coatings	  presenting	  the	  RGD	  peptide	  have	  also	  been	  used	  to	  control	  the	  adhesion	  of	  cells.148	  Furthermore,	  studies	  of	  cellular	  responses	  to	  soluble	  agents,	  
e.g.	   drugs	   and	   fixation	   reagents,	   also	   suit	   the	   QCM-­‐D	   technique.	   It	   has	   been	  demonstrated	   that	   alterations	   in	   the	   cytoskeleton,	   caused	   by	   e.g.	   cytochalasin	  D149,	  150	  or	  nocodazole151,	  are	  detected	  by	  QCM(-­‐D).	  In	  particular,	  one	  trend	  that	  has	  been	  noted	  is	  that	  the	  cortical	  actin	  cytoskeleton	  is	  a	  major	  contributor	  to	  the	  cellular	   acoustic	   response.152	   The	   cellular	   responses	   are	   also	   predominantly	  attributed	   to	   changes	   close	   to	   the	   sensor	   surface,	   i.e.	   to	   the	   cell	   substrate	  interface.	  Naturally,	  due	  to	  the	  limited	  penetration	  depth	  of	  the	  sensor,	  changes	  occurring	  close	  to	  the	  sensor	  surface	  are	  likely	  to	  generate	  acoustic	  responses.	  It	  should	   be	   noted,	   however,	   that	   the	   cause	   of	   the	   observed	   responses	   not	  necessarily	   needs	   to	  be	   localized	   close	   to	   the	   substrate,	   it	   could	  be	   an	   indirect	  effect	  (within	  the	  penetration	  depth)	  that	   is	  sensed.	  For	  example,	   in	  a	  study	  by	  Cans	   et.	   al.	   exocytosis	   and	   retrieval	   of	   exocytosed	   vesicles	   from	   the	   upper	  membrane	   generated	   responses	   in	   both	   Δf	   and	   ΔD.153	   In	   that	   study	   it	   was	  speculated	  that	  the	  variation	  in	  membrane	  area,	  and	  the	  resulting	  change	  in	  the	  lateral	   tension	   of	   the	   membrane,	   generated	   the	   observed	   responses.	   An	  alternative	  explanation	  of	  the	  observed	  responses	  could	  be	  based	  on	  the	  possible	  tensegrity	   of	   the	   cytoskeleton.	   Tensegrity	   is	   one	   model	   of	   the	   mechanical	  properties	   of	   the	   cytoskeleton,	   stating	   that	   the	   cell	   stiffness	   is	   roughly	  proportional	   to	   the	   intracellular	   stress.154	   In	   the	   process	   of	   exocytosis	   (and	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endocytosis)	   the	   cytoskeleton	  will	  be	  affected	  and	   remodeled,	   and	  despite	   that	  the	   processes	   occur	   at	   the	   apical	   cell	   membrane	   the	   intracellular	   strain	  (tensegrity)	  will	  enable	  acoustic	  detection	  close	  to	  the	  substrate.	  The	  concept	  of	  tensegrity	  was	  first	  described	  by	  the	  architect	  R.	  Buckmeister	  Fuller	   in	  1961155	  and	  is	  nicely	  visualized	  by	  the	  artist	  K.	  Snelson.	  In	   line	  with	   the	   aim	   of	   the	  work	   presented	   in	   this	   thesis,	   QCM	  has	   recently	  been	   applied	   to	   study	   cytotoxic	   effects	   of	   nanomaterials,	   specifically	  macrophages	  were	  exposed	   to	   single	  walled	  carbon	  nanotubes.156	  Additionally,	  in	   the	  same	  study,	  phagocytosis	  of	  nanoparticles	  (non-­‐toxic	  polystyrene	  beads)	  was	  probed	  for	  the	  first	  time	  using	  QCM.	  
5.3 AFM Atomic	   force	   microscopy	   (AFM)	   belongs	   to	   a	   family	   of	   scanning	   probe	  microscopy	   techniques	   that	   stems	   from	   the	   scanning	   tunneling	   microscopy	  (STM)	   technique	   developed	   in	   the	   early	   1980´s.	   The	   invention	   of	   the	   AFM	   in	  1986	   made	   it	   possible	   to	   analyze	   all	   surfaces,	   not	   only	   the	   ones	   that	   are	  electrically	  conductive	  as	  is	  the	  case	  for	  STM.	  This	  advantage,	  together	  with	  the	  possibility	  to	  perform	  analyses	  in	  liquid	  environments,	  opened	  up	  the	  door	  to	  the	  field	   of	   biology.	   From	  now	  on	   it	  was	   possible	   to	   resolve	   features	   on	   biological	  samples	  much	  smaller	  than	  the	  optical	  diffraction	  limit.157	  The	  four	  main	  components	  in	  a	  typical	  instrument	  are	  the	  cantilever	  to	  which	  a	  sharp	  tip	  is	  attached,	  an	  optical	  system	  used	  to	  detect	  cantilever	  deflection,	  the	  piezoelectric	  translation	  system,	  and	  the	  feedback	  circuitry	  (Figure	  17).	  The	  cantilever	  is	  usually	  fabricated	  from	  silicon	  or	  silicon	  nitride	  and	  has	  a	  spring	  constant	  between	  0.01	  and	  100	  N/m.	  The	  piezoelectric	  translation	  system	  typically	  consists	  of	  a	  tube	  made	  from	  a	  piezoelectric	  ceramic.	  This	  system	  raster	  scans	  the	  tip	  over	  the	  sample,	  where	  the	  movements	  can	  be	  controlled	  with	  high	  accuracy	  in	  three	  dimensions.	  The	  optical	  deflection	  system	  measures	  the	  bending	  of	  the	  cantilever	  that	  in	  turn	  is	  dependent	  on	  the	  tip-­‐sample	  interaction	  (i.e.	  “force”).	  	  An	  AFM	  analysis	   can	   be	   performed	   either	   in	   contact	   or	   in	   tapping	  mode.	   In	  contact	  mode	  the	  tip	  will	  be	  in	  constant	  contact	  with	  the	  surface,	  and	  the	  image	  is	   created	   from	   either	   the	   bending	   of	   the	   cantilever	   or	   the	   movements	   of	   the	  cantilever	   base	   in	   the	   z-­‐direction.	   These	   two	   ways	   of	   detection	   are	   called	  constant	  height	  and	  constant	  force,	  respectively.	  In	  the	  latter	  case	  the	  data	  from	  the	   optical	   deflection	   system	   is	   fed	   into	   a	   feedback	   loop,	   which	   keeps	   the	  deflection	   of	   the	   cantilever	   (i.e.	   the	   force)	   constant.	   In	   tapping	   mode	   the	  cantilever	  is	  made	  to	  oscillate	  close	  to	  its	  natural	  resonance	  frequency.	  When	  the	  tip	  comes	  in	  close	  contact	  with	  the	  surface,	  the	  oscillation	  amplitude	  will	  change	  due	   to	   tip-­‐sample	   interaction.	   When	   the	   tip	   is	   scanned	   across	   a	   surface,	   the	  amplitude	   is	   kept	   constant	   by	   the	   feedback	   loop,	   and	   the	   necessary	   scanner	  height	  adjustments	  are	  used	  to	  form	  an	  image.	   In	  this	  work,	  only	  contact	  mode	  AFM	  at	  constant	  force	  has	  been	  applied.	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  Figure	  17.	  Schematic	  illustration	  of	  an	  AFM	  setup.	  The	  AFM	   can	   also	   be	  used	   for	   force	   spectroscopy,	   i.e.	   the	   force	   is	  measured	  versus	   the	   distance	   between	   the	   tip	   and	   the	   sample	   at	   a	   fixed	   lateral	   position.	  With	   force	   spectroscopy,	   intermolecular	   forces	   can	   be	  measured	   and	   the	   force	  spectra	  can	  indicate	  the	  length	  or	  thickness	  of	  an	  investigated	  object.158	  This	  is	  a	  good	  way	   to	  detect	   the	  presence	  of	   a	  SLB	  on	  a	   surface.	   Since	   the	  membrane	   is	  very	   flat	   and	   faithfully	   follows	   the	   contours	   of	   the	   underlying	   substrate,	   a	  topographic	   image	  will	  not	  easily	  reveal	   its	  presence.	  The	  outcome	  of	   the	   force	  spectra	  will	  however	  be	  different	  if	  a	  membrane	  is	  present	  compared	  to	  the	  bare	  surface.	  
5.4 DPI Dual	   polarization	   interferometry	   (DPI)	   is	   a	   surface	   sensitive	   analytical	  technique	  developed	  in	  the	  early	  2000s.159	  The	  technique	  is	  based	  on	  a	  dual	  slab	  waveguide	   and	   similarly	   to	   other	   analytical	   techniques,	   e.g.	   SPR	   and	   TIRF,	   it	  relies	  on	  an	  evanescent	   field	   that	  extends	  100-­‐200	  nm	  from	  the	  sensor	  surface	  into	   the	   liquid	   compartment.	   The	  DPI	  waveguide	   consists	   of	   an	   upper	   sensing	  waveguide	   and	   a	   lower	   reference	   waveguide	   where	   the	   top	   surface	   of	   the	  sensing	  waveguide	  is	  the	  actual	  sensor	  surface.	  The	  principle	  of	  the	  DPI	  setup	  is	  illustrated	  in	  Figure	  18.	  Polarized	  laser	  light	  (λ	  =623.8	  nm)	  is	  applied	  at	  one	  end	  of	  the	  waveguides,	  and	  as	  the	  light	  propagates	  along	  the	  sensing	  waveguide	  the	  phase	  of	  the	  light	  changes	  in	  relation	  to	  the	  adsorption	  events	  that	  take	  place	  on	  the	   sensor	   surface.	   	   In	   the	   lower	  waveguide,	   the	   light	   is	   not	   influenced	   by	   the	  adsorption	   events.	   When	   the	   light	   reaches	   the	   far	   end	   of	   the	   waveguides,	   it	  diverges	   and	   is	   allowed	   to	   combine.	   In	   this	  way	   interference	   fringes,	   light	   and	  dark	  bands,	  are	  formed	  and	  can	  be	  detected	  on	  a	  screen	  positioned	  beyond	  the	  waveguides.	   The	   position	   of	   the	   interference	   fringes	   depends	   on	   the	   phase	  relationship	   of	   the	   light	   from	   the	   two	  waveguides.	   In	   this	  way	   it	   is	   possible	   to	  relate	   the	   adsorption	   events	   with	   a	   measurable	   output.	   Two	   orthogonal	  polarizations	   of	   the	   incident	   light,	   transverse	   magnetic	   (TM)	   and	   transverse	  electric	   (TE),	   are	   used.	   	   These	   two	   polarizations	   generate	   independent	  measurements	  that	  respond	  differently	  to	  binding	  events	  on	  the	  sensor	  surface.	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From	   the	   two	   measurements,	   the	   density	   and	   the	   thickness	   of	   the	   adsorbed	  material	  can	  be	  extracted	  using	  classical	  optical	  theory.	  	  
 
	  Figure	  18.	  Schematic	  of	  the	  DPI	  setup.	  Laser	  light	  is	   introduced	  into	  two	  parallel	  waveguides	  in	  the	  sensor	  chip	  and	  interference	  fringes	  are	  formed	  in	  the	  far	  end.	  The	  position	  of	  these	  fringes	  is	  dependent	   on	   the	   phase	   shift	   of	   the	   light	   traveling	   in	   the	   sensing	   waveguide,	   which	   in	   turn	  depend	  on	  the	  mass	  deposition	  on	  the	  sensor	  surface.	  The	  polarizer	  is	  omitted	  from	  the	  figure	  for	  increased	  clarity.	  
 Until	   now,	   DPI	   has	   been	   applied	   in	   many	   different	   fields	   of	   research,	   e.g.,	  protein	   adsorption160	   and	   lipid	  membrane	   formation161,	  162.	  With	   DPI	   it	   is	   also	  possible	   to	   address	   the	   anisotropic	   properties	   of	   the	   adsorbed	   material.	   As	  opposed	   to	   isotropic	  materials,	   the	   properties	   of	   anisotropic	  materials	   depend	  on	  the	  direction.	  For	  example,	  the	  refractive	  index	  of	  a	  material,	  or	  molecule,	  in	  the	  x	  and	  y	  dimensions	  (nx	  and	  ny)	  may	  differ	  from	  the	  refractive	  index	  in	  z	  (nz).	  In	   DPI	   analyses	   it	   is	   possible	   to	   study	   the	   anisotropic	   properties	   of	   lipids	   in	   a	  supported	  membrane.	  In	  this	  case,	  the	  lipid	  molecules	  are	  ordered	  perpendicular	  to	   the	  sensor	  surface,	  a	  structure	   that	  generates	  a	  positive	  birefringence	   in	   the	  DPI	  data	  analysis.	  Birefringence	  is	  the	  difference	  between	  the	  extraordinary	  (ne)	  and	   the	   ordinary	   (no)	   refractive	   index	   of	   the	   material	   on	   the	   surface.	   This	  difference	   corresponds	   well	   to	   the	   difference	   in	   refractive	   index	   determined	  using	  the	  TM	  and	  TE	  polarizations	  of	  the	  incident	  light	  (nTM-­‐nTE).	  In	  Figure	  19	  the	  difference	  between	  anisotropy	  and	  birefringence	  is	  shown.	  
 
	  Figure	  19.	  The	  refractive	  index	  of	  anisotropic	  materials	  is	  directionally	  dependent,	  i.e.,	  nx	  and	  ny	  differ	  from	  nz.	  The	  difference	  between	  the	  extraordinary	  refractive	  index	  (ne)	  (ne	  ≈	  nTM)	  and	  the	  ordinary	  refractive	  index	  (no)	  (no	  ≈	  nTE)	  is	  termed	  birefringence	  and	  is	  determined	  in	  the	  DPI	  data	  evaluation.	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5.5 Reflectometry In	  contrast	  to	  QCM-­‐D,	  reflectometry	  is	  an	  optical	  technique.	  This	  difference	  in	  sensing	  principle	  makes	  the	  two	  techniques	  an	  excellent	  complement	  to	  one	  and	  other.	  While	  QCM-­‐D	  senses	  the	  hydrated	  mass	  (macoustic)	  associated	  to	  the	  sensor	  surface,	  optical	  techniques	  only	  detects	  the	  “dry”	  mass	  (moptic).	  	  When	  combining	  the	   two	   techniques	   the	   degree	   of	   hydration	   of	   the	   adsorbed	  material	   could	   be	  determined.115	  Reflectometry	   is	  based	  on	   the	   fact	   that	   the	  optical	  property,	   the	  reflectivity,	  of	  a	  surface	  changes	  when	  mass	  is	  adsorbed	  to	  it.	  The	  surface	  under	  study	  is	  illuminated	  through	  a	  prism	  with	  monochromatic,	  plane	  polarized	  light	  at	  a	  certain	  angle	  of	  incidence.	  The	  reflected	  light	  is	  split	  in	  two	  components	  with	  different	   polarizations	   and	   the	   intensity	   ratio	   (S)	   of	   these	   two	   polarizations	   is	  monitored.	  This	  ratio	  changes	  when	  adsorption/desorption	  processes	  occurs	  at	  the	  surface	  and	  the	  relative	  changes	  is	  given	  as	  the	  output	  ΔR.	  ∆! = !!!!!! 	   	   	   	   	   	   (8)	  S0	  corresponds	  to	  the	  initial	  intensity	  ratio,	  i.e.	  only	  buffer.	  The	  optical	  output,	  ΔR,	  is	  related	  to	  the	  adsorbed	  mass	  through	  the	  following	  equations	  ∆! = ! ∙ (! − !!) ∙ !	   	   	   	   (9)	  !!"#$% = !∙(!!!!)!"/!" 	   	   	   	   	   (10)	  Where	  d	  is	  the	  thickness	  of	  the	  adsorbed	  layer	  and	  n	  its	  refractive	  index,	  A	  is	  the	  sensitivity	  factor	  and	  dn/dc	  id	  the	  refractive	  index	  increment	  of	  the	  adsorbed	  material.163	   In	   this	   work	   a	   prototype	   instrument	   of	   combined	   QCM-­‐D	   and	  reflectometry	   has	   been	   used.	   This	   enables	   the	   two	   techniques	   to	   be	   used	  simultaneously,	  at	  the	  same	  sensor	  surface,	  and	  the	  degree	  of	  hydration	  (H)	  to	  be	  determined.	  ! = !!"#$%&'"!!!"#$%!!!"#$%&! 	   	   	   	   (11)	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6 
Summary of the appended papers 
6.1 Brief summary of papers In	   this	   thesis,	   interactions	  at	   the	  nano-­‐bio	   interface	  are	  explored,	   an	  area	  of	  research	  that	  is	  currently	  intensively	  investigated.123,	  164-­‐166	   	  The	  understanding	   of	   these	   interactions	   is	   of	   great	   importance	   from	   both	   a	  nanotoxicological	   and	  a	  nanomedical	   perspective.	   Interactions	  between	   certain	  nanomaterials	  and	  lipid	  bilayers,	  the	  main	  constituent	  of	  biological	  membranes,	  have	   been	   investigated	   in	   detail	   using	   surface	   sensitive	   analytical	   techniques.	  These	   techniques	   are	   further	   described	   in	   Chapter	   5.	   In	   Paper	   I	   and	   II,	   the	  properties	   of	   engineered	   polyelectrolyte	   complexes	   (PECs)	   consisting	   of	  polycationic	  polymers	  and	  human	  insulin	  were	  investigated.	  Differently	  charged	  supported	   lipid	  membranes	  were	  exposed	  to	   these	  nano-­‐sized	  PECs	  and	   it	  was	  shown	   that	   the	   interactions	   were	   mainly	   mediated	   by	   electrostatics.	  Furthermore,	   structural	   deformation	   of	   the	   PECs	   occurred	   upon	   adsorption	   to	  the	   lipid	   membranes,	   a	   process	   that	   was	   not	   expected	   by	   the	   researches	   that	  developed	   these	   PECs.	   Engineered	   features	   of	   PECs	   (pH-­‐sensitivity	   and	  sensitivity	   to	   a	   reductive	   environment)	   were	   also	   evaluated.	   In	  Paper	   III,	   the	  interactions	   between	   graphene	   oxide	   and	   lipid	   membranes	   were	   investigated.	  The	   results	   showed	   that	   graphene	   oxide	   adsorbed	   flat	   onto	   positively	   charged	  lipid	   membranes.	   Interestingly,	   it	   was	   proven	   possible	   to	   build	   multilamellar	  structures	   of	   graphene	   oxide	   and	   lipid	  membranes	   in	   a	   layer-­‐by	   layer	   fashion.	  Sequential	  addition	  of	  liposomes	  and	  graphene	  oxide	  resulted	  in	  the	  formation	  of	  additional	  lipid	  membranes	  with	  adsorbed	  graphene	  oxide.	  More	  specifically,	  the	  liposomes	  adsorbed	  intact	  on	  the	  graphene	  oxide	  surface	  and	  were	  ruptured	  by	  the	   graphene	   oxide	   upon	   the	   next	   addition.	   The	   resulting	   bio/nonbio	  nanocomposite	  structure	  may	  serve	  as	  a	  scaffold	  for	  the	  utilization	  of	  advanced	  biomolecular	   functions.	   In	   Paper	   IV,	   TiO2	   NPs,	   commonly	   used	   in	   consumer	  products,	  were	  studied	  with	  respect	  to	  their	  lipid	  membrane	  interactions.	  It	  was	  found	   that	   these	   NPs	   induced	   rupture	   of	   POPG-­‐containing	   lipid	   membranes.	  Furthermore,	  it	  was	  elucidated	  that	  the	  removal	  of	  lipid	  material	  was	  dependent	  on	  the	  presence	  of	  Ca2+	  ions.	  Upon	  repeated,	  and	  sequential,	  addition	  of	  Ca2+	  ions	  and	   TiO2	   NPs	   more	   lipids	   were	   extracted	   from	   the	   supported	   membrane.	  Subsequent	  addition	  of	  liposomes,	  restored	  the	  disrupted	  lipid	  membrane.	  	  In	  the	  final	  part	  of	  this	  thesis	  the	  membrane	  model	  system	  was	  substituted	  for	  living	   cells.	   In	   this	   way,	   the	   complexity	   of	   the	   biological	   interface	   increased	  tremendously.	   By	   studying	   living	   cells	   it	   was	   no	   longer	   possible	   to	   address	  fundamental	  aspects	  regarding	  the	  lipid	  membrane	  upon	  nanoparticle	  exposure.	  However,	  it	  was	  now	  possible	  to	  address	  intracellular	  processes	  in	  real-­‐time.	  In	  
Paper	   V,	  Xenopus	   laevis	  (African	   clawed	   frog)	  melanophores	  were	   cultured	  on	  QCM-­‐D	   sensor	   surfaces	   and	   the	   responses	   obtained	   upon	   transport	   of	  melanosomes	   (pigment	   granules)	   were	   characterized.	   In	   this	   paper	   the	  utilization	  of	  QCM-­‐D	  to	  study	  melanophores	  was	  addressed	  both	  from	  a	  QCM-­‐D	  and	   a	   cell	   biology	   perspective.	   The	   paper	   formed	   a	   basis	   to	   subsequent	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experiments	   where	   the	   effect	   of	   nanomaterials	   to	   the	   intracellular	   transport	  processes	  was	  addressed.	  
6.2 Experimental platform for nanomaterial – lipid membrane 
interactions The	   three	   main	   components	   in	   the	   applied	   experimental	   platform	   were	  nanomaterials,	   lipid	   molecules	   and	   surface	   sensitive	   analytical	   techniques.	   In	  addition,	  the	  nanomaterials	  were	  characterized	  using	  light	  scattering	  methods	  to	  determine	  their	  size	  distribution	  and	  zeta	  (ζ)	  potential.	  The	  first	  component,	  the	  nanomaterials,	   was	   selected	   based	   on	   two	   major	   factors,	   availability	   and	  suitability.	   Naturally,	   the	   nanomaterials	   had	   to	   be	   available	   in	   sufficient	  quantities	  to	  enable	  the	  analyses,	  either	  from	  collaborators	  or	  from	  commercial	  sources.	  In	  my	  research,	  I	  have	  not	  developed	  any	  nanomaterials	  on	  my	  own.	  In	  addition	   to	   the	   availability,	   the	   nanomaterials	   had	   to	   be	   suitable	   for	   in	   vitro	  studies,	   i.e.,	   they	   had	   to	   be	   well	   defined	   and	   synthesized	   in	   a	   reproducible	  manner.	   It	   has	   also	   been	   an	   aim	   to	   include	   studies	   of	   significantly	   dissimilar	  nanomaterials	   in	   this	   thesis.	   The	   second	   component,	   the	   lipid	   molecules,	   was	  chosen	   partly	   due	   to	   the	   presence	   in	   native	   cell	   membrane	   and	   partly	   due	   to	  their	  charge.	  By	  combining	  lipids	  of	  different	  net	  charge	  it	  was	  possible	  to	  tune	  the	  charge	  of	  the	  resulting	  lipid	  membrane.	  See	  section	  4.1.2	  for	  further	  details	  regarding	  lipid	  molecules.	  The	  third,	  and	  last,	  main	  component	  of	  the	  described	  experimental	   platform	   is	   the	   experimental	   techniques.	   Several	   methods	   were	  used	  to	   investigate	   the	  nanomaterial-­‐	   lipid	  membrane	   interactions,	   these	  were:	  QCM-­‐D,	  reflectometry,	  AFM	  and	  DPI.	  QCM-­‐D	  was	  chosen	  to	  be	  the	  main	  method	  of	  analysis	  due	   to	   the	  gained	  structural	   information	  of	   the	  NP-­‐SLB	   interactions	  and	   the	   relatively	   high	   throughput.	   In	   addition	   to	   QCM-­‐D,	   techniques	   giving	  complementary	   information	  were	   applied	   to	   support	   the	   interpretation	   of	   the	  studied	  surface	  associated	  interaction	  processes.	  In	  the	  following	  sections	  the	  results	  obtained	  in	  studies	  of	  insulin-­‐loaded	  drug	  carriers,	  graphene	  oxide	  and	  TiO2	  NPs	  are	  described	   in	  some	  detail.	  Additional	  details	  are	  given	  in	  the	  appended	  papers.	  
6.2.1 Insulin-loaded drug carriers (Paper I and II) In	  paper	  I	  and	  II,	  different	  insulin	  loaded	  PECs	  have	  been	  studied	  with	  respect	  to	  their	   lipid	  membrane	  interactions.	  Also,	   in	  the	   latter	  paper,	   functionalities	  of	  the	   PECs	   were	   evaluated.	   As	   a	   first	   step,	   all	   types	   of	   prepared	   PECs	   were	  characterized	  with	  respect	  to	  their	  size	  and	  charge.	  These	  types	  of	  analysis	  were	  mainly	   performed	   using	   dynamic	   (size)	   and	   electrophoretic	   (charge)	   light	  scattering.	   The	   preferred	   sample	   should	   have	   a	   low	   polydispersity	   and	   a	   low	  variation	  of	  the	  mean	  size	  between	  different	  batches.	  In	  Paper	  I,	  the	  investigated	  NP	  (referred	  to	  as	  NP-­‐HI)	  was	  analyzed	  with	  both	  DLS	  and	  SEM	  (Figure	  20).	  The	  hydrodynamic	   diameter	   was	   determined	   to	   approximately	   220	  nm	   by	   DLS.	   In	  contrast,	   the	   size	   revealed	  by	   electron	  microscopy	  was	  much	   smaller	   (d	  <	  100	  nm).	  The	  large	  difference	  between	  these	  results	  was	  due	  to	  the	  hydration	  of	  the	  analyzed	  NPs.	  Prior	  to	  the	  SEM	  analysis,	  the	  sample	  are	  dried	  and	  the	  analysis	  is	  preformed	  under	  vacuum	  conditions	  whereas	   the	  DLS	  analysis	   is	  preformed	   in	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liquid.	   Naturally,	   these	   different	   sample	   preparations	   yield	   particles	   with	  different	  size.	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  Figure	   21.	   QCM-­‐D	   data	   (z	   =	   3,	   5,	   7,	   9,	   11	   and	   13)	   of	   the	   interaction	   between	  NP-­‐HI	   and	   three	  differently	  charged	  model	  membranes.	  Larger	  frequency	  and	  dissipation	  shifts	  were	  obtained	  for	  lower	   overtone	   numbers.	   (A)	   Positively	   charged	   POPC:POEPC	   (3:1),	   (B)	   negatively	   charged	  POPC:POPS	  (3:1)	  and	  (C)	  slightly	  negatively	  charged	  POPC.	  The	  plots	  show	  a	  sequence	  of	  events	  including	  (1)	  baseline	  in	  buffer,	  (2)	  addition	  of	  NP-­‐HI	  and	  (3)	  buffer	  rinse.	  The	  preceding	  steps	  of	  bilayer	  formation	  and	  buffer	  exchange	  were	  omitted	  in	  the	  plots.	  (Paper	  I)	  	  To	   further	   investigate	   the	   structural	   differences	   between	   these	   two	   cases,	  they	  were	  analyzed	   in	  a	  combined	  QCM-­‐D/reflectometry	  setup.	  The	  aim	  of	   this	  analysis	   was	   to	   compare	   the	   two	   different	   structural	   arrangements	   of	   the	  adsorbed	   NPs	   with	   respect	   to	   their	   degree	   of	   hydration.	   For	   NP-­‐HI	   layers	  adsorbed	  on	  a	  POPC:POPS	  (3:1)	  membrane,	  macoustic	  and	  moptic	  were	  calculated	  as	  described	   in	   section	  5.2	   and	  5.5	   respectively,	   and	   the	  degree	  of	   hydration	  was	  determined	   to	   approximately	   70%.	   The	   thicker	   layer	   formed	   by	   adsorption	   of	  NP-­‐HI	  to	  a	  plain	  POPC	  membrane	  generated	  a	  decrease	  in	  the	  optical	  signal	  (ΔR).	  At	  first	  this	  result	  seemingly	  suggests,	  in	  contrast	  to	  the	  QCM-­‐D	  data	  that	  mass	  is	  lost	  from	  the	  surface.	  However,	  the	  negative	  optical	  signal	  was	  to	  be	  expected	  for	  thicker	  films	  of	  the	  adsorbed	  material,	  based	  on	  optical	  modeling	  of	  the	  system.	  	  	  When	  NPs	  are	  taken	  up	  by	  a	  cell	  through	  endocytosis	  they	  are	  subjected	  to	  a	  low	  pH	   in	   the	   late	  endosome.	  This	  change	   in	   the	  surrounding	  environment	  can	  be	   utilized	   to	   trigger	   the	   release	   of	   the	   drug	   from	   its	   carrier.	   Similarly,	   the	  intracellular	   reductive	   environment	   can	   be	   used	   to	   disintegrate	   the	   carrier	   to	  promote	   drug	   release.	   In	   paper	   II,	   three	   different	   responsive	   PECs	   based	   on	  poly(amido	  amine)s	  were	  produced	  and	  evaluated.	  These	  NPs	  were	  responsive	  
1 2 3 
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to	  reducing	  agents	  due	  to	  the	  presence	  of	  disulfide	  linkages167	  in	  the	  backbone	  of	  the	  polymers.	  The	  NPs,	  which	  are	  referred	   to	  as	  NP	  1-­‐3,	  were	  also	  designed	   to	  disintegrate	   when	   pH	   was	   decreased	   from	   physiological	   to	   about	   5	   due	   to	   a	  strong	  decrease	  in	  the	  charge	  attraction	  between	  the	  polymer	  and	  the	  protein	  at	  this	   low	   pH.	   In	   this	   study,	   the	   NPs	   were	   first	   adsorbed	   to	   a	   preformed	  POPC:POPS	  (3:1)	  membrane.	  Subsequently,	  the	  ambient	  conditions	  were	  altered	  either	   by	   adding	   a	   reducing	   agent	   (glutathione)	   or	   by	   decreasing	   the	   pH.	   As	  expected,	  NPs	  containing	  disulfide	  linkages	  in	  the	  polymer	  backbone	  responded	  to	   the	   presence	   of	   glutathione	   while	   the	   NP	   without	   disulfide	   linkages	   was	  unaffected	   by	   the	   addition	   of	   glutathione.	   The	   previously	   adsorbed	   NPs	  containing	   disulfide	   linkages	   dissociated	   from	   the	   membrane.	   The	   QCM-­‐D	  frequency	   shift	   Δf	   suggested	   that	   the	   intact	   lipid	   membrane	   remained	   on	   the	  surface.	  The	  percent	  of	  the	  adsorbed	  NP	  mass	  that	  dissociated	  from	  the	  surface	  in	  the	  three	  different	  cases	  are	  presented	  in	  Figure	  22A.	  	  In	   addition,	   NP	   1	   was	   evaluated	   with	   respect	   to	   its	   pH-­‐sensitivity.	   After	  adsorption	  to	  a	  POPC:POPS	  membrane	  and	  subsequent	  buffer	  rinse,	  the	  pH	  was	  decreased	   from	  7.3	   to	   5.1	   using	   a	   pH-­‐gradient	   lasting	   for	   one	  hour.	   The	   result	  shows	  that	  mass	  start	  to	  dissociate	  from	  the	  surface	  at	  a	  pH	  of	  approximately	  6.5.	  After	  this	  point,	  a	  rapid	  mass	  release	  occurs	  until	  a	  pH-­‐value	  of	  about	  6.	  Finally,	  at	   pH	   5.1,	   the	   mass	   loss	   has	   leveled	   out	   at	   a	   level	   where	   20	   %	   of	   the	   initial	  amount	  of	  mass	  is	  left	  on	  the	  membrane.	  The	  result	  is	  presented	  in	  Figure	  22B.	  	  
	  Figure	  22.	  Response	  of	   the	  adsorbed	  NPs	   to	   (A)	  addition	  of	  a	   reducing	  agent	   (glutathione)	  and	  (B)	  a	  decrease	  in	  pH.	  (Paper	  II)	  The	  scenario	  suggested	  by	  the	   interpretation	  of	   the	  QCM-­‐D	  data	  was	   further	  strengthened	   by	   AFM	   measurements.	   The	   adsorption	   of	   NP	   1	   to	   the	   model	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membrane	   and	   its	   response	   to	   glutathione	  was	   evaluated	  by	   imaging	   after	   the	  formation	  of	   the	  SLB,	  after	  adsorption	  of	  NPs,	  and	  after	  addition	  of	  glutathione	  (Figure	  23).	  Corresponding	  force	  spectra	  were	  also	  recorded.	  The	  bare	  SLB	  was	  detected	   by	   a	   kink	   in	   the	   force	   spectrum	   originating	   from	   when	   the	   tip	   was	  pressed	   through	   the	   SLB	   during	   its	   approach	   towards	   the	   surface.	   After	  adsorption	   of	  NP	   1,	   this	   characteristic	   kink	   corresponding	   to	   the	   SLB	  was	   still	  present.	   In	  addition,	   forces	  were	  exerted	  on	   the	   tip	  several	   tens	  of	  nanometers	  away	  from	  the	  surface.	  This	  event	  in	  the	  force	  spectrum	  reveals	  the	  presence	  of	  the	  adsorbed	  NP	  material.	  Another	  main	  difference	   in	   the	   force	   spectrum	  after	  addition	  of	  NPs	  was	  the	  pull	  off	   force.	  Before	  addition	  of	  NPs	  the	  pull	  off	  was	  a	  distinct	  event	  where	  the	  tip	  snapped	  off	  the	  surface,	  while	  after	  addition	  of	  NPs	  the	   pull	   off	   occurred	   much	   more	   slowly.	   After	   addition	   of	   glutathione	   two	  different	   regions	   were	   revealed	   on	   the	   surface.	   Although	   the	   SLB	   could	   be	  detected	   in	   both,	   the	   force	   spectra	   suggested	   that	   in	   one	   of	   the	   regions	   an	  additional	  thin	  layer	  of	  NP	  material	  was	  present.	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surface	  remained.	  Both	  the	  presented	  cases	  where	  adsorbed	  NPs	  dissociate	  from	  the	   surface	   due	   to	   particle	   disintegration	   were	   most	   likely	   associated	   with	  release	  of	  the	  insulin	  drug	  load.	  However,	  to	  follow	  the	  release	  of	  insulin	  from	  its	  carrier	  other	  methods	  must	  be	  applied	  which	   in	  most	  cases	  require	   labeling	  of	  the	  insulin	  molecules.	  
6.2.2 Graphene oxide (Paper III) In	  paper	  III,	  QCM-­‐D	  analyses	  show	  that	  graphene	  oxide	  adsorb	  selectively	  to	  positively	   charged	   supported	   lipid	   membranes	   (POPC:POEPC	   (3:1)),	   i.e.,	   the	  interactions	   are	   mainly	   due	   to	   electrostatic	   forces.	   The	   magnitude	   of	   the	  observed	   frequency	   shifts	   corresponded	   well	   to	   the	   predicted	   shift	   of	   an	  adsorbed	  monolayer	  of	  graphene	  oxide	  (~-­‐6	  Hz).	  Furthermore,	  the	  absence	  of	  a	  response	  in	  dissipation	  upon	  adsorption	  indicated	  that	  the	  graphene	  oxide	  flakes	  adsorbed	  flat	  onto	  the	  lipid	  membrane.	  These	  results	  were	  further	  supported	  by	  the	   DPI	   analyses	  where	   the	   dry	  mass	   of	   the	   adsorbed	   graphene	   oxide	   and	   its	  birefringence	  were	  determined.	  By	   comparing	   the	  mass	  determined	  by	  QCM-­‐D	  and	  DPI	  the	  hydration	  level	  of	  the	  graphene	  oxide	  layer	  was	  determined	  to	  32%.	  Such	  difference	  in	  mass	  is	  commonly	  observed	  when	  comparing	  acoustically	  and	  optically	  derived	  data.	  More	  noteworthy	   is	   the	  observed	  negative	  birefringence	  of	  the	  graphene	  oxide	  layer.	  The	  origin	  of	  the	  negative	  birefringence	  is	  the	  larger	  polarizability	  of	  the	  adsorbed	  graphene	  oxide	  in	  the	  plane	  parallel	  to	  the	  sensor	  surface	   compared	   to	   the	   direction	   normal	   to	   that	   plane.	   In	   Figure	   24,	   the	  anisotropic	   properties	   of	   both	   the	   lipid	   membrane	   and	   the	   layer	   of	   graphene	  oxide	  are	  evident	  through	  the	  difference	  between	  the	  transverse	  magnetic	  (TM)	  and	   transverse	   electric	   (TE)	   responses.	   TM	   and	   TE	   are	   two	   orthogonal	  polarizations	   of	   the	   incident	   light.	   See	   section	  5.4	   for	   further	   details	   regarding	  the	  DPI	  technique.	  For	  isotropic	  materials	  TM	  is	  always	  larger	  than	  TE,	  however	  in	   the	   case	  of	   graphene	  oxide	   adsorbed	   to	   a	   lipid	  membrane	   the	   situation	  was	  reversed.	  This	  unusual	  scenario	  yielded	  a	  negative	  birefringence.	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to	   investigate	  how	   liposomes	   interacted	  with	   a	   graphene	  oxide	   coated	   surface.	  Since	  the	   liposomes	  were	  of	   the	  same	   lipid	  composition	  as	   the	  underlying	   lipid	  membrane,	  possible	   interactions	  were	  only	  expected	  at	   the	  areas	  covered	  with	  graphene	  oxide.	  The	  result	  showed	  that	  POPC:POEPC	  (3:1)	   liposomes	  adsorbed	  intact	  on	  top	  of	  the	  graphene	  oxide	  flakes.	  This	  result	  was	  clearly	  evident	  due	  to	  the	   large	   positive	   dissipation	   shift	   upon	   addition	   of	   liposomes.	   However,	   if	  graphene	  oxide	  was	  added	  to	  the	  intact	  liposomes	  the	  high	  dissipation	  returned	  to	   a	   very	   low	   level,	   indicating	   that	   graphene	   oxide	   induced	   rupture	   of	   the	  liposomes.	   The	   additions	   of	   liposomes	   and	   graphene	   oxide	   were	   cycled	   up	   to	  three	   times	  and	   for	  each	  cycle	  more	  material	  was	  deposited	  at	   the	  surface	   in	  a	  layer-­‐by-­‐layer	   fashion.	   The	   QCM-­‐D	   and	   DPI	   data	   of	   the	  multilayer	   buildup	   are	  shown	  in	  Figure	  25.	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  Figure	   26.	   Schematic	   representation	   of	   the	   buildup	   of	   a	   multilayered	   structure	   consisting	   of	  POPC:POEPC	  (3:1)	  lipid	  bilayers	  and	  graphene	  oxide.	  	  In	   the	  AFM	   images,	   presented	   in	  Figure	  27,	   adsorbed	  graphene	  oxide	   flakes	  were	   visualized,	   both	   after	   the	   first	   addition	   and	   after	   three	   additions.	   When	  analyzing	   the	   images	   recorded	   after	   three	   cycles	   of	   added	   liposomes	   and	  graphene	   oxide,	   it	   was	   revealed	   that	   some	   specific	   heights	   occurred	   more	  frequently	   than	   others	   on	   the	   surface.	   We	   interpreted	   these	   heights	   to	   be	  multiples	  of	  a	  lipid	  bilayer	  with	  adsorbed	  graphene	  oxide.	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Taken	  together,	  paper	  III	  presents	  data	  on	  the	  interactions	  between	  graphene	  oxide	  and	  supported	  lipid	  membranes	  as	  well	  as	  supported	  liposomes.	  Also	  the	  reverse	   situation,	   where	   a	   surface	   coated	   with	   liposomes	   was	   exposed	   to	  graphene	   oxide,	   was	   explored.	   In	   addition,	   the	   formation	   of	   a	   novel	  nanocomposite	  structure	  consisting	  of	  alternating	  layers	  of	  lipid	  membranes	  and	  graphene	  oxide	  was	  shown.	  
6.2.3 TiO2 nanoparticles (Paper IV) In	   paper	   IV,	   supported	   lipid	  membranes	   composed	   of	   POPC	   and	  POPG	   lipid	  molecules	  were	  exposed	   to	  TiO2	  NPs	  of	   about	  60	  nm.	   J.P.	  Holmerg	   synthesized	  these	   NPs	   via	   hydrolysis	   of	   TiCl4.168	   The	   synthesis	   took	   place	   in	   an	   acidic	  environment	  and	  produced	  particles	  in	  the	  size	  range	  of	  7-­‐20	  nm.	  The	  size	  of	  the	  NPs	  increased	  to	  around	  60	  nm	  during	  the	  subsequent	  shift	  in	  pH,	  from	  2.5	  to	  8.	  The	  main	  crystal	  structure	  of	  these	  NPs	  was	  anatase.	  	  F.	   Zhao	   exposed	   POPC:POPG	   (1:1)	   supported	   lipid	   membranes	   to	   the	  synthesized	   TiO2	   NPs.	   The	   QCM-­‐D	   data	   indicated	   that	   the	   membranes	   were	  disrupted	  by	  the	  NP	  exposure,	  a	  process	  that	  was	  dependent	  on	  the	  presence	  of	  Ca2+	   ions.	  Upon	  repeated	  exposures	  and	  additions	  of	  Ca2+,	  more	  and	  more	   lipid	  mass	   was	   removed	   from	   the	   sensor	   surface.	   In	   my	   analyses,	   I	   confirmed	   the	  presence	  of	  holes	   in	   the	   lipid	  membrane	  after	  exposure	   to	   the	  TiO2	  NPs.	   In	   the	  AFM	  images,	  holes	  much	  larger	  than	  the	  size	  of	  the	  NPs	  were	  observed.	  This	  was	  most	   likely	   due	   to	   the	   fluidity	   of	   the	   lipid	   membrane.	   When	   small	   holes	   are	  formed	   the	   lipids	   rearrange	   to	   a	  more	   energetically	   favorable	   state	   and	   in	   this	  process	   the	   small	   holes	  merge	   into	   larger	   ones.	   In	   the	   AFM	   analyses	   the	   lipid	  membrane	  was	   detected	   by	   force	   spectroscopy.	   This	  method	  was	   also	   used	   to	  probe	   the	   absence	   of	   the	   lipid	   membranes	   in	   the	   observed	   holes.	   The	   height	  profile	   of	   the	   holes	   corresponded	   well	   to	   the	   expected	   thickness	   of	   a	   lipid	  membrane	  (about	  5	  nm).	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6.3 Monitoring of intracellular transport by QCM-D (Paper 
V) In	   paper	   V,	   the	   use	   of	   QCM-­‐D	   to	   detect	   and	   monitor	   the	   translocation	   of	  melanosomes	  in	  Xenopus	  laevis	  melanophores	  was	  explored.	   If	  possible,	  QCM-­‐D	  may	   be	   used	   to	   monitor	   changes	   of	   intracellular	   transport	   processes	   upon	  nanomaterial	  exposure.	  The	  results	  showed	  significant	  responses	  in	  both	  Δf	  and	  
ΔD	  upon	  melanosome	  transport	  induced	  by	  MSH	  or	  melatonin	  (Figure	  29).	  Thus,	  QCM-­‐D	   is	   a	   new	   tool	   to	   be	   used	   in	   the	   studies	   of	   melanophores	   and	   of	  intracellular	   transport	   processes.	   In	   this	   thesis,	   the	   use	   of	  melanophores	   is	   an	  extension	   of	   the	   experimental	   platform	   described	   in	   section	   6.2,	   i.e.	   the	   well-­‐defined	  lipid	  membranes	  used	  in	  paper	  I-­‐IV	  were	  substituted	  to	  living	  cells.	  	  With	  this	  substitution	  the	  complexity	  of	  the	  system	  increased	  tremendously,	  however	  real-­‐time	  studies	  of	  intracellular	  processes	  was	  enabled.	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“bleached”	   melanophores,	   i.e.	   melanophores	   lacking	   pigment,	   were	   then	  compared	   to	   untreated	   melanophores	   in	   QCM-­‐D	   analyses.	   Third,	   the	  melanosome	   transport	   was	   studied	   upon	   disruption	   of	   cytoskeletal	   filaments	  (actin	   filaments	   and	   microtubules).	   When	   breaking	   down	   these	   structures,	  transport	  along	  such	  filaments	  was	  prohibited.	  Last,	  the	  vertical	  redistribution	  of	  melanosomes	   upon	   dispersion	   and	   aggregation	   was	   studied	   by	   confocal	  microscopy.	  Dispersed	   melanosomes	   makes	   the	   skin	   of	   the	   animal	   darker	   compared	   to	  when	  the	  melanosomes	  are	  in	  an	  aggregated	  state,	  i.e.,	  the	  melanophores	  absorb	  more	  light	  in	  the	  former	  case.	  For	  this	  reason,	  the	  reflectance	  of	  the	  cell-­‐coated	  surface	   was	   measured	   simultaneously	   as	   the	   QCM-­‐D	   responses.	   The	   results	  presented	   in	   Figure	   30,	   clearly	   showed	   that	   the	   observed	   shift	   in	   frequency	  correlated	  well	  with	  the	  reflectance	  of	  the	  sample	  surface.	  Hence,	  the	  frequency	  shift	  correlates	  well	  to	  the	  state	  of	  melanosome	  distribution.	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of	   MSH	   did	   not	   yield	   a	   response.	   This	   is	   in	   accordance	   with	   the	   fact	   that	  dispersion	  of	  melanosomes	  occurs	  along	  actin	  filaments.	  If	  no	  such	  filaments	  are	  present,	  melanosomes	  cannot	  be	  transported	  to	  the	  cell	  periphery.	  Aggregation	  however,	   which	   takes	   place	   along	   micrutubules,	   still	   yielded	   a	   detectable	  response.	  In	  the	  case	  of	  nocodazole,	  there	  were	  no	  significant	  responses	  in	  Δf	  and	  
ΔD	   upon	   addition.	   Surprisingly,	   the	   responses	   during	   the	   dispersion	   and	  aggregation	  cycle	  in	  the	  presence	  of	  nocodazole	  were	  similar	  to	  the	  one	  prior	  to	  the	   addition	   (Figure	   31).	   Seemingly,	   the	   observed	   responses	   did	   not	   originate	  from	  transport	  along	  microtubules.	  Taken	  together,	  the	  results	  indicate	  that	  the	  response	  recorded	  during	  dispersion	  is	  due	  to	  melanosome	  transport	  along	  actin	  filaments.	   However,	   the	   data	   do	   not	   clarify	   the	   origin	   of	   the	   response	   during	  melanosome	  aggregation.	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aggregated	  state.	  In	  the	  latter	  state,	  the	  melanosomes	  are	  clustered	  deeper	  into	  the	   cell.	   Thus,	   one	   model	   for	   the	   origin	   of	   the	   QCM-­‐D	   responses	   is	   given	   as	  follows.	   Transport	   of	   melanosomes	   to	   and	   from	   a	   volume	   close	   to	   the	   sensor	  surface,	  covered	  by	  the	  first	  and	  third	  harmonics,	  give	  rise	  to	  detectable	  QCM-­‐D	  responses.	  	  The	   distribution	   of	   melanosomes	   in	   the	   dimension	   extending	   out	   from	   the	  substrate	  (z-­‐dimension)	  was	  analyzed	  by	  confocal	  microscopy.	  The	  results	  show	  that	   there	   was	   a	   distinct	   difference	   in	   the	   melanosome	   distribution	   in	   the	   z-­‐dimension,	   between	   the	   dispersed	   and	   aggregated	   state	   (Figure	   32).	   In	   the	  dispersed	   state	   there	  was	   a	   large	   number	   of	  melanosomes	   close	   to	   the	   sensor	  surface	   compared	   to	   the	   aggregated	   state.	   Thus,	   the	   distribution	   of	   distances	  between	   the	   melanosomes	   and	   the	   substrate	   differs	   significantly	   between	   the	  dispersed	  and	   the	  aggregated	  state.	  These	  data	  support	   the	  reasoning	   that	   it	   is	  the	  transport	  of	  melanosomes	  to	  and	  from	  a	  volume	  close	  to	  the	  sensor	  surface	  that	  generate	  the	  observed	  QCM-­‐D	  responses.	  	  
	  Figure	  32.	  The	  figure	  shows	  confocal	  microscopy	  images	  of	  two	  melanophores,	  one	  in	  the	  aggregated	  state	  (left	  column)	  and	  the	  other	  in	  the	  dispersed	  state	  (right	  column).	  	  For	  each	  of	  these	  two	  states	  the	  actin	  filaments,	  and	  hence	  the	  footprints	  of	  the	  cells,	  are	  shown	  in	  a	  plane	  close	  to	  the	  substrate.	  In	  the	  same	  plane,	  and	  in	  a	  plane	  2	  μm	  above,	  the	  melanosome	  distributions	  are	  shown.	  For	  comparison,	  transmission	  images	  and	  3D	  side	  views	  of	  the	  melanosome	  distributions	  of	  the	  two	  cells	  are	  included.	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6.3.1 Effects of SiO2 nanoparticle exposure (Additional results) As	  a	   continuation	  of	   the	  work	  presented	   in	  Paper	  V,	   experiments	  where	   the	  melanophores	   were	   exposed	   to	   SiO2	   NPs	   were	   performed.	   These	   experiments	  may	  bee	  seen	  as	  further	  downstream	   in	  vitro	  characterization	  of	  nanomaterials	  compared	   to	   the	   previously	   presented	   studies	   of	   model	   lipid	   membranes.	   In	  these	  experiments,	  the	  complexity	  of	  the	  system	  is	  much	  greater	  than	  in	  the	  well	  controlled	  interaction	  experiments	  using	   lipid	  membranes.	  A	  series	  of	  SiO2	  NPs	  was	   obtained	   from	  EKA	   chemicals	   (Bohus,	   Sweden),	   a	   company	   that	   produces	  large	  quantities	  of	  SiO2	  NPs	   for	  use	   in	  paper	  products.	  Due	  to	  the	   large	  volume	  produced	   and	   the	   various	   surface	   functionalizations	   available,	   these	  NPs	  were	  chosen	  to	  be	  used	   in	   the	  present	  experiments.	  The	  set	  of	  SiO2	  NPs	  consisted	  of	  clean	  (uncoated)	  NPs,	  NPs	  functionalized	  with	  isobutyl-­‐groups	  (iBu),	  or	  PEG	  and	  isobutyl-­‐groups	   (PEG/iBu),	   and	   rod-­‐shaped	  NPs	   composed	   of	   smaller	   SiO2	  NPs	  (Figure	  33).	  According	  to	  specifications,	  the	  spherical	  NPs	  had	  a	  diameter	  of	  20	  nm	  while	  the	  smaller	  NPs	  in	  the	  SiO2-­‐rods	  had	  a	  diameter	  of	  3-­‐4	  nm	  (determined	  from	  titration	  of	  the	  specific	  surface	  area).	  The	  length	  of	  the	  rod	  shaped	  NPs	  was	  about	  20	  nm.	  However,	   the	  hydrodynamic	  diameters	  of	   the	  spherical	  NPs	  were	  determined	  to	  about	  40	  nm	  by	  DLS,	  when	  diluted	  in	  water.	  The	  size	  distributions	  are	  shown	  in	  Figure	  33.	  By	  using	  this	  set	  of	  NPs	  it	  was	  possible	  to	  address	  both	  the	  effects	  of	  surface	  functionalization	  and	  to	  compare	  spherical	  NPs	  to	  NPs	  with	  high	   aspect	   ratio.	   Generally,	   high	   aspect	   ratio	   nanoparticles,	   e.g.	   nanotubes,	  nanorods,	   nanowires,	   and	   nanofibers,	   are	   considered	   more	   toxic	   than	   their	  spherical	   counterparts.169	   The	   main	   reason	   for	   this	   is	   the	   resemblance	   to	  asbestos	  fibers.	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Xenopus	   laevis	  melanophores,	   pre-­‐cultured	   on	  QCM-­‐D	   sensor	   surfaces,	  were	  exposed	  to	  the	  SiO2	  NPs	  (50	  μg/mL,	  24	  h)	  ex	  situ.	  The	  exposure	  was	  performed	  in	  serum	   containing	   culture	  medium.	   It	   is	   important	   to	   note	   that	   the	   added	   NPs	  will,	   depending	   on	   their	   functionalization,	   adsorb	   serum	  proteins	   and	  possibly	  aggregate/agglomerate	  in	  the	  culture	  medium.	  To	  analyze	  these	  effects,	  the	  NPs	  were	   studied	   by	  DLS	  when	  diluted	   to	   50	   μg/mL	   in	  water	   and	   culture	  medium	  respectively.	  The	  preliminary	  results	  are	  presented	   in	  Figure	  33.	  Subsequently,	  the	   sensors	   were	   mounted	   in	   a	   QCM-­‐D	   E4	   instrument	   and	   the	   intracellular	  transport	  of	  melanosomes	  was	  sequentially	  induced	  by	  MSH	  and	  melatonin.	  The	  recorded	   shifts	   during	  melanosome	  dispersion	   and	   aggregation	  of	   the	   exposed	  cells	  were	  then	  compared	  to	  responses	  obtained	  using	  unexposed	  control	  cells.	  By	   this	   methodology	   it	   is	   possible	   to	   probe	   the	   impact	   of	   NP	   exposure	   on	  melanosome	  transport	  processes.	  If	  an	  effect	  of	  NP	  exposure	  would	  be	  observed,	  the	  next	   step	  may	  be	   to	   expose	   the	   cells	   in	  situ,	   during	   a	  QCM-­‐D	  analyses,	   and	  possibly	  detect	  a	  response	  in	  real-­‐time.	  Here,	  the	  response	  during	  dispersion	  of	  melanosomes	   was	   chosen	   as	   an	   experimental	   endpoint.	   The	   results	   showed	   a	  significant	  variation	  of	  the	  responses	  between	  different	  replicates,	  including	  the	  unexposed	  control	  (Figure	  34).	  One	  likely	  explanation	  for	  this	  is	  the	  variation	  of	  the	  starting	  material.	  It	  is	  not	  certain	  that	  the	  cell	  density	  and	  the	  cell	  adhesion	  to	  the	   substrate	  were	   similar	  between	   the	  different	   replicates,	   although	   the	   same	  number	  of	  cells	  was	  seeded	  and	  the	  culture	  time	  was	  kept	  the	  same.	  Despite	  the	  variation	  in	  result	  between	  different	  experiments,	  there	  are	  some	  indications	  in	  the	  obtained	  data.	   Exposure	   to	   the	   SiO2	   rods	   gave	  hampered	   responses	  during	  melanosome	   dispersion	   compared	   to	   the	   responses	   of	   the	   unexposed	   control	  cells.	   In	  contrast,	  cells	  exposed	  to	  the	  iBu/PEG-­‐coated	  SiO2	  NPs	  generated	  large	  responses	   in	   the	   same	   process.	   When	   comparing	   the	   results	   of	   these	   two	  exposures	   there	   were	   significant	   differences	   between	   the	   recorded	   QCM-­‐D	  responses.	  These	  differences	   indicated	  that	  primarily	  the	  shape	  of	  the	  SiO2	  NPs	  had	  an	  impact	  on	  the	  melanosome	  transport	  process.	  	  	  





























	   57	  
7 
Concluding remarks and future 
perspectives In	   brief,	   this	   thesis	   has	   contributed	   to	   the	   development	   of	   in	   vitro	  characterization	   methods	   for	   engineered	   nanomaterials.	   The	   presented	   data	  show	  the	  kind	  of	  information	  that	  may	  be	  extracted	  by	  studying	  the	  interactions	  between	   nanomaterials	   and	   model	   lipid	   membranes	   using	   surface	   based	  analytical	   techniques,	   both	   regarding	   the	   intrinsic	   properties	   of	   the	  nanomaterials	  and	  the	  effects	  exerted	  on	  the	  lipid	  membranes.	  Furthermore,	  this	  thesis	  has	  extended	  the	  use	  of	  the	  QCM-­‐D	  technique	  to	  detection	  of	  intracellular	  transport	   processes.	   This	   possibility	   enables	   studies	   focusing	   on	   the	   effect	   of	  nanomaterials	  on	  such	  processes.	  One	   key	   point	   that	   is	   of	   great	   significance	   for	   this	   work	   is	   the	   Janus-­‐faced	  nature	  of	  nanomaterals.	  On	  one	  hand,	   the	  unique	  properties	  of	   these	  materials	  are	   promising	   for	   a	   wide	   range	   of	   applications.	   While	   on	   the	   other	   hand,	   the	  increased	  use	  and	  production	  volumes	  of	  nanomaterials	  pose	  a	  potential	  risk	  for	  adverse	  effects	  on	  the	  human	  health	  or	  the	  environment.	  As	  in	  the	  last	  decades,	  the	   future	  development	  of	   engineered	  nanomaterials	  will	  most	   likely	   continue.	  Due	   to	   this,	   it	   is	   of	   most	   importance	   that	   we	   learn	   to	   take	   advantage	   of	   the	  benefits	   that	   nano-­‐sized	  materials	   bring	   in	   a	   safe	   and	   responsible	  manner.	   To	  accomplish	  this,	  there	  is	  a	  need	  for	  a	  definite	  definition	  of	  what	  a	  nanomaterial	  is.	  Such	   definition	   would	   enable	   legislation	   against	   potentially	   hazardous	  nanomaterials	   and	   make	   labeling	   of	   commercial	   products	   that	   contain	  nanomaterials	   possible.	   However,	   there	   is	   also	   a	   need	   for	   methodologies	   for	  better	   characterization	   of	   nanomaterials.	   The	   characterization	   process	  may	   be	  seen	   as	   a	   screening	   hierarchy	   that	   starts	   with	   the	   basic	   physico-­‐chemical	  properties	   and	   ends	  with	   in	  vivo-­‐studies.	   The	   large	  number	   of	   descriptors	   of	   a	  nanomaterial,	   compared	   to	   a	   chemical	   compound,	   put	   high	   demands	   on	   the	  characterization	  already	  at	   an	  early	   stage.	  The	   studies	  presented	   in	   this	   thesis,	  where	   nanomaterial-­‐lipid	   membrane	   interactions	   were	   investigated,	   may	   be	  seen	   as	   an	   intermediate	   characterization	   step	   in	   the	   screening	   hierarchy.	  Upstream	   of	   these	   analyses	   is	   the	   physico-­‐chemical	   characterization,	   and	  downstream	  comes	  in	  vitro	  cell	  assays	  and	  in	  vivo	  testing.	  I	  believe	  that	  there	  is	  a	  need	  for	  novel	  characterization	  techniques	  and	  methodologies	  at	  many	  stages	  in	  the	  screening	  process.	  Possibly,	  additional	  intermediate	  steps	  could	  be	  added	  to	  the	   mentioned	   hierarchy	   for	   a	   more	   thorough	   characterization.	   Due	   to	   the	  versatility	   of	   engineered	   nanomaterials	   the	   strategy	   adopted	   by	   OECD,	   to	  intensively	   study	   few	   selected	   nanomaterials	   and	   extrapolate	   the	   results	   to	  others	   by	   SARs,	   is	   crucial.	   From	   the	   risk	   perspective,	   it	   is	   necessary	   that	   the	  knowledge	  of	  potential	  hazards	  of	  a	  novel	  nanomaterial	  is	  sufficient	  prior	  to	  its	  use	   in	   commercial	   products.	   To	   achieve	   this,	   the	   risk	   assessment	   needs	   to	  progress	  rapidly.	  	  The	  model	   lipid	  membranes	   that	  were	  used	   in	   the	   studies	  presented	   in	   this	  thesis	  could	  be	  viewed	  in	  two	  different	  ways.	  Either	  they	  are	  seen	  as	  very	  simple	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models	  of	  a	  native	  cell	  membrane,	  or	  as	  model	  surfaces	  with	  tunable	  properties	  (by	  changing	  the	  lipid	  composition).	  In	  the	  first	  case,	  future	  efforts	  could	  be	  put	  in	   preparing	  more	   native-­‐like	  model	   cell	  membranes	   at	   surfaces.	   This	  may	   be	  achieved	   by	   either	   a	   bottom-­‐up	   approach,	   where	   membrane	   constituents	  subsequently	   are	   inserted	   into	   the	   supported	   lipid	   membrane,	   or	   a	   top-­‐down	  approach,	   where	   native	   cell	  membranes	   are	   extracted	   and	   put	   on	   the	   surface.	  Neither	  of	  these	  approaches	  is	  trivial	  to	  pursue	  but	  they	  would	  both	  be	  valuable	  for	   research	   in	   this	   and	   other	   areas.	   If	   the	   lipid	   membranes	   are	   seen	   from	   a	  different	  perspective,	  as	  well	  defined	  model	  surfaces,	  the	  surface	  based	  analyses	  of	  nanomaterial	   interactions	  may	  be	  directly	   applied	   as	   a	   characterization	   tool	  for	  these	  materials.	  Obtained	  data	  from	  lipid	  membrane	  interaction	  studies	  may	  also	  be	  used	  to	  evaluate	  engineered	  nanomaterials	  and	  aid	  further	  development	  thereof.	  The	  use	  of	  acoustic	  sensing	  in	  cell	  studies	  is	  increasing.	  However,	  there	  is	  still	  much	   to	   learn	   regarding	   interpretation	   of	   the	   acquired	   data.	   Cell	   attachment,	  spreading,	   and	  proliferation	  on	  surfaces	  could	  be	  evaluated	  using	  such	  sensing	  techniques	  but	  merely	  on	  a	  qualitative	  basis.	  There	  is	  a	  need	  for	  the	  development	  of	  theoretical	  models	  to	  extract	  quantitative	  information	  from	  the	  analyses,	  e.g.,	  on	  the	  viscoelastic	  properties	  of	  the	  cells.	  Such	  models	  may	  also	  predict	  possible	  effects	   of	   the	   surface	   coating	   on	   the	   recorded	   responses.	   At	   the	   same	   time	   as	  more	  work	  is	  needed	  to	  interpret	  and	  model	  data,	  there	  is	  also	  a	  need	  for	  further	  development	   of	   the	   instruments.	   The	   possibility	   to	   combine	   e.g.	   QCM-­‐D	   and	  fluorescence	   microscopy	   would	   facilitate	   interpretation	   of	   the	   acoustic	   data.	  Generally,	  combining	  an	  acoustical	  and	  an	  optical	  sensing	  technique	  derive	  much	  information	   from	   the	   system	   under	   study.	   For	   this	   reason,	   more	   analytical	  techniques	  will	  most	  likely	  be	  combined	  to	  allow	  simultaneous	  measurements.	  A	  specific	  example	  recently	  initiated	  in	  my	  research	  project	  aims	  to	  combine	  QCM-­‐D	  and	  localized	  surface	  plasmon	  resonance	  (LSPR)	  to	  probe	  cellular	  processes.	  I	  believe	   that	   the	   possibility	   to	   investigate	   cellular	   responses	   in	   real	   time	   will	  enable	  a	  continued	  development	  in	  this	  area	  of	  research.	  This	  type	  of	  studies	  will	  most	  likely	  become	  important	  for	  in	  vitro	  characterization	  of	  nanomaterials.	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